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We have been producing an annual report on infectious diseases in Maine for the last 17 years. 
This report is published by the Division of Infectious Disease and is intended to provide an 
overview of communicable diseases of public health importance in Maine.   
 
We could not produce this report without the continued support of our healthcare and public 
health partners throughout the state. We greatly appreciate all of the laboratories, healthcare 
providers, day care centers, school nurses and others who provide disease surveillance 
information. They have expended considerable time investigating infectious diseases with 
Maine CDC that impact Maine residents. Their active and critical role in the infectious disease 
surveillance cycle translates into statewide policies and programs that protect our residents from 
infectious disease through health promotion, disease prevention, and early detection, 
containment, and treatment.   
 
We encourage our partners’ continued support and vigilance in the effort to protect the people of 
Maine through timely, complete, and accurate infectious disease reporting. The better we are 
able to prevent and control disease now, the better positioned we are to respond to emerging 
infectious disease threats in the future.   
 
For more information on what, when, and how to report infectious disease please see Appendix 
F (Notifiable Conditions List) of this report, visit our website at www.mainepublichealth.gov, or 
call 1-800-821-5821.      
 
We hope you find this report useful as we all work to protect and promote the health of Maine’s 
residents. We welcome any feedback on how we can provide disease information to you, our 
partners.  
 
 
  
Peter Smith, Ph.D 
Director, Division of Infectious Disease 
Maine Center for Disease Control and 
Prevention 
Stephen Sears, MD, MPH 
State Epidemiologist 
Maine Center for Disease Control and 
Prevention 
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2010 Infectious Disease Surveillance Highlights 
 
• Lyme disease cases decreased in 2010, but overall five year trends showed an 
increase. Lyme disease is the most common vectorborne disease reported in Maine. 
• Syphilis cases doubled in 2010. Half of the reported cases were co-infected with HIV. 
Targeted testing continues for high risk individuals. 
• Chlamydia remained the most commonly reported infectious disease in the state with 
2,586 cases.  Seventy percent of reported infections were in persons 15-24 years of 
age.  
• Foodborne illness outbreaks affected Maine residents and were multistate and 
multinational. Two cases of STEC O26 in Maine and one case in New York State led to 
the first recall of ground beef due to a non-O157 contaminant; ground beef is routinely 
tested for E. coli O157 only. 
• Cryptosporidiosis cases increased each year for the previous few years. Starting in 2010 
the State Health and Environmental Laboratory performed enhanced testing and 
collaborated with the federal CDC for species analysis. The goal for 2011 is to gather 
more information using a new questionnaire to look at possible exposures.  
• Group A Streptococcus (GAS) infections increased in the winter of 2010, as did 
streptococcal toxic shock syndrome (STSS). The reasons for the increase are unclear. 
Federal CDC performed testing on a few cases and identified different strains of GAS 
circulating in the state. 
• In 2010 the case definition for invasive Streptococcus pneumoniae changed to include 
all invasive cases. In previous years the focus was only on drug resistant organisms and 
children under the age of 5 years. 
• Maine had the lowest rate of tuberculosis in the country at 3.7 per 100,000 persons. 
• 62 wild animals tested positive for rabies (28 raccoons, 20 skunks, 5 bats, 7 foxes and 1 
woodchuck and one feral cat). Maine has not had a human case since 1937. 
• More norovirus outbreaks were reported in December of 2010 compared to previous 
years. 
• Vaccine preventable diseases continue in Maine, especially pertussis and varicella, 
highlighting the need to promote childhood and adult vaccinations. 
• Diseases associated with international travel increased in Maine with reported typhoid 
fever, dengue fever, malaria and various foodborne illnesses. As international travel 
becomes easier and residents visit areas with endemic infectious diseases, there is a 
need to emphasize preventive strategies among travelers. 
• Hospital acquired infections, especially Staphylococcus bacteria resistant to methicillin 
(MRSA) are an increasing focus of public health.  
• In Maine, the continued blooms of toxic algae (red tide) remind us that we live in a fragile 
environment effected by climate, rainfall, human use and animals. 
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Overview of Public Health Surveillance 
The responsibility of government to control and prevent disease dates back hundreds of years.  
Government responsibility was exercised during the epidemics of plague, syphilis, and smallpox 
in the Middle Ages to identify possible sources of disease, isolate infectious cases, and 
quarantine their contacts to prevent further spread of infection.  Illness was monitored, 
regulations were enacted to prevent pollution of streets and public water supplies, and 
instructions were made for appropriate methods of burial and food handling.  
 
Infectious disease surveillance in the United States began soon after the colonies were 
established.  In 1741, Rhode Island passed legislation requiring tavern keepers to report 
contagious disease among their patrons. Two years later, Rhode Island enacted legislation 
requiring the reporting of smallpox, yellow fever, and cholera. National disease surveillance 
began in 1850, when mortality statistics were first published by the federal government based 
on the decennial census.  The legal requirement to collect national morbidity data in the United 
States was initiated in 1878 when Congress authorized the US Public Health Service to collect 
reports of the occurrence of quarantineable diseases including cholera, plague, smallpox, and 
yellow fever.   
 
In 1885, the Maine State Board of Health was created and consisted of six members appointed 
by the Governor.  Disease reporting for a select few diseases was conducted by the State 
Board of Health.  In 1917 the Board was replaced by the Department of Health. 
 
In 2010, 71 infectious diseases were reportable in Maine and 64 are considered nationally 
reportable.  The list of reportable infectious diseases in Maine changes periodically, the last 
update was in 2008.  Diseases may be added to the list as new pathogens emerge or when a 
previously recognized pathogen becomes more important.  Also, some diseases may be 
removed from the list as their incidence or importance declines.  While modern advances in 
sanitation, personal hygiene and immunizations serve to provide greater control and prevention 
of some diseases, other infectious diseases continue to thrive and still other yet-to-be-identified 
infectious disease entities are constantly emerging.   
 
The DHHS Maine Center for Disease Control and Prevention (Maine CDC) works with 
healthcare providers and laboratorians to gather infectious disease information, analyze it, and 
provide reports in a timely manner. Surveillance data are useful for identifying situations that 
require immediate public health action, such as disease outbreaks; identifying emerging 
diseases, including identifying populations at higher risk of infection; monitoring trends in the 
burden of disease; guiding the planning, implementation and evaluation of disease prevention 
and treatment programs; and forming public policy, including the allocation of heathcare 
resources.  
 
The public health "patient" is the community, and information about that community can be 
useful to the clinician providing care to the individual.  Partnership between public health 
professionals and healthcare providers is critical to assure accurate, representative and timely 
information for all.  
 
Disease Reporting in Maine  
Healthcare providers, medical laboratories, healthcare facilities, administrators, health officers, 
veterinarians and others are required to report notifiable diseases to the Maine Center for 
Disease Control and Prevention.   
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Diseases that are possible indicators of bioterrorism and other diseases requiring specific and 
prompt public health response are to be reported immediately.  The remainder of notifiable 
conditions are to be reported within 48 hours of recognition or strong suspicion of disease. 
 
Disease reports may be made by electronic laboratory report (ELR), telephone or fax to the 
Maine Center for Disease Control and Prevention 24 hours a day, 7 days a week. The reporting 
numbers are toll free: telephone 1-800-821-5821 and fax 1-800-293-7534.  An epidemiologist is 
on call 24 hours a day, 7 days a week to respond to public health emergencies.  Disease 
reports may also be mailed to the Division of Infectious Disease, 286 Water Street, 8th Floor, 11 
State House Station, Augusta, Maine 04333-0011.  Non-confidential reports or requests for 
consultation can be sent by email to disease.reporting@maine.gov.  
 
Infectious disease and notifiable conditions reportable in Maine are listed on the Maine Center 
for Disease Control and Prevention website, along with the Rules for the Control of Notifiable 
Conditions and current information regarding infectious disease incidence in Maine (available at 
http://www.maine.gov/dhhs/boh/ddc/epi/disease-reporting/index.shtml).  
 
The Health and Environmental Testing Laboratory (HETL) tests for most reportable conditions, 
and certain organisms are required to be sent to HETL for confirmatory testing. More 
information on the testing performed at HETL is available at www.mainepublichealth.gov/lab. 
 
Purpose of Report 
The Reportable Infectious Diseases in Maine 2010 Summary fulfills multiple functions.  First, it 
allows public health officials to quantify the magnitude of certain problems.  For example, 
surveillance data demonstrates the spread of deer ticks and Lyme Disease within Maine.  
Second, the report allows us to evaluate the effectiveness of our prevention measures.  For 
example, the incidence of vaccine-preventable diseases provides evidence about the 
effectiveness of the state’s immunization program.  Third, data in the report allow us to detect 
changes in healthcare practice, such as whether hepatitis B vaccine and immune globulin are 
being given at birth to children born to women who are chronic carriers.  Fourth, the report helps 
us plan for future events.  For example, data on HIV and AIDS help to establish the need for 
treatment resources, including antiviral medications for the indigent.  Finally, the report serves 
as an historical document of public health surveillance data, providing information on the 
descriptive epidemiology of reportable infectious diseases in Maine.    
 
Methods 
The data in this report are based on case definitions developed by the Council of State and 
Territorial Epidemiologists (CSTE) and adopted by the Maine Center for Disease Control and 
Prevention. Case definitions may change from year to year. The current case definitions are 
available at http://www.cdc.gov/osels/ph_surveillance/nndss/PHS/infdis2011.htm. Cases 
meeting the confirmed or probable case definitions are presented in the annual report.  
 
Tables in the introduction section include all confirmed and probable cases used by the federal 
CDC for their weekly and annual reports unless otherwise noted.  Rates are calculated by 
dividing the number of cases by the appropriate population from the U.S. Census estimates for 
each particular year and multiplying by 100,000.  
 
Charts and graphs may not total the same number as actual cases due to missing information, 
such as county of residence, symptom onset date, age and gender. 
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Selected Reportable Disease Counts by Year, Maine, 2001 - 2010 
Disease 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 
Anaplasmosis (HGE) 1 1 1 1 4 10 9 17 15 17 
Babesiosis 1 2 3 5 11 9 11 11 3 5 
Campylobacteriosis 124 139 146 141 159 137 149 151 171 148 
Chlamydia 1346 1801 2040  2120 2253 2304 2543 2594 2443 2586 
Cryptosporidiosis 20 12 20 22 30 52 56 46 67 93 
Dengue Fever^ 0 0 0 0 1 4 1 2 3 6 
Ehrlichia chaffeensis (HME)^ 0 0 0 0 1 4 3 1 1 4 
Giardiasis 197 212 184 155 202 192 197 188 223 223 
Gonorrhea 141 142 231  214 142 137 118 96 143 162 
Group A Streptococcal 
Disease (invasive) 
12 20 28 16 14 19 28 28 21 47 
Group B Streptococcal 
Disease, Infant (invasive) 
1 5 2 1 3 1 1 6 2 8 
H. Influenzae (invasive) 2 2 6 15 12 21 13 21 21 13 
Hemolytic uremic syndrome  1 3 0 2 0 6 1 1 2 1 
Hepatitis A, acute 11 9 16 16 9 8 5 18 1 7 
Hepatitis B, acute 7 14 7 11 14 26 19 15 15 13 
Hepatitis B, chronic NA NA NA NA NA NA 140 143 126 101 
Hepatitis C, acute 1 0 2 0 0 2 1 3 2 2 
HIV Infection 40 39 65  46 59 62 64 46 56 59 
Legionellosis 8 6 2 1 7 11 9 11 10 12 
Listeriosis 2 5 6 8 3 6 5 5 4 1 
Lyme disease 108 217 175 224 245 338 528 908 970 751 
Malaria 5 6 5 6 5 4 8 1 2 6 
Meningococcal disease 10 9 10 12 2 9 8 6 4 5 
MRSA, invasive NR NR NR NR NR NR NR 47 120 90 
Mumps 0 0 0 0 2 0 24 5 6 2 
Pertussis 22 21 91 195 55 174 83 49 80 53 
Rabies, animal 85 67 82 69 61 127 86 64 56 62 
Salmonellosis 166 147 141 108 163 161 138 159 121 133 
Shiga toxin producing E. coli* 31 49 15 18 29 49 41 26 19 21 
Shigellosis 6 10 7 13 15 10 14 20 5 8 
Streptococcus pneumoniae, 
invasive 
NA NA NA NA NA NA NA NA NA 130 
Streptococcus pneumoniae 
(drug resistant invasive) 
NR NR 0 4 8 12 13 18 23 30 
Syphilis (early) 4 3 15  2 3 16 14 20 14 39 
Tuberculosis 20 23 24  20 17 16 19 9 9 8 
Varicella (Chickenpox) 146 792 1012 363 318 238 366 269 235 247 
Vibriosis 1 4 3 4 2 5 0 3 4 5 
*Shiga toxin producing E. coli (STEC) was a new condition in 2006 that includes all previously 
reported enterohemorrhagic E. coli cases. 
^Reported cases were probable only. 
NR = not reportable 
NA = not available
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Reportable Diseases with Historically Small Numbers of Cases, Maine, 2001 - 2010 
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 10 year total 
Anthrax 0 0 0 0 0 0 0 0 0 0 0 
Botulism, foodborne 0 2 0 1 0 0 0 0 0 0 3 
Brucellosis 0 0 0 0 0 0 0 0 0 2 2 
Creutzfeld-Jacob disease (<55 yo) NR NR 0 0 0 0 0 0 1 0 1 
Cyclosporiasis 0 0 0 1 0 0 0 0 0 1 2 
Diphtheria 0 0 0 0 0 0 0 0 0 0 0 
Encephalitis, Arboviral 2 0 0 1 0 0 0 0 0 0 3 
Hantavirus Pulmonary Syndrome 0 0 0 0 0 0 0 0 0 0 0 
Measles 0 0 0 0 0 0 0 0 0 0 0 
Plague 0 0 0 0 0 0 0 0 0 0 0 
Q fever 0 0 2 0 2 4 7 0 0 0 15 
Psittacosis 0 0 0 1 0 0 0 0 0 0 1 
Poliomyelitis 0 0 0 0 0 0 0 0 0 0 0 
Rubella 0 0 0 0 0 0 0 0 0 0 0 
Rocky Mountain Spotted Fever^ NR NR NR NR NR NR NR 1 5 2 8 
Severe Acute Respiratory 
Syndrome (SARS) NR NR 0 0 0 0 0 0 0 0 0 
Smallpox 0 0 0 0 0 0 0 0 0 0 0 
Tetanus 0 1 0 0 0 0 0 0 0 0 1 
Streptococcal Toxic Shock 
Syndrome 0 1 1 1 0 0 1 0 0 21 25 
Toxoplasmosis 1 0 0 1 0 0 0 0 0 0 2 
Trichinosis 0 0 0 0 0 0 0 0 0 1 1 
Tularemia 0 0 0 0 0 0 0 0 0 0 0 
Typhoid Fever 0 0 0 0 0 1 0 0 0 2 3 
Venezuelan Equine Encephalitis NR NR 0 0 0 0 0 0 0 0 0 
West Nile Virus  NR NR 0 0 0 0 0 0 0 0 0 
Yellow Fever NR NR NR 0 0 0 0 0 0 0 0 
NR=Not reportable, ^Reported cases were probable only 
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   Selected Reportable Diseases in Maine, 2010
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2010 
 Anaplasmosis Babesiosis Campylobacteriosis Cryptosporidiosis Ehrlichia 
chaffeensis 
Giardiasis 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 0 0.0 0 0.0 10 9.4 3 2.8 0 0.0 18 16.9 
Aroostook 0 0.0 0 0.0 9 12.7 7 9.9 0 0.0 2 2.8 
Cumberland 3 1.1 0 0.0 34 12.3 5 1.8 0 0.0 82 29.7 
Franklin 0 0.0 0 0.0 4 8.0 1 3.4 0 0.0 4 13.5 
Hancock 0 0.0 0 0.0 8 15.0 6 11.3 0 0.0 16 30.0 
Kennebec 0 0.0 0 0.0 15 12.4 13 10.7 0 0.0 15 12.4 
Knox 1 2.5 1 2.5 1 2.5 1 2.5 0 0.0 5 12.3 
Lincoln 5 14.5 1 2.9 6 17.5 6 17.5 1 2.9 1 2.9 
Oxford 1 1.8 0 0.0 6 10.7 0 0.0 1 1.8 13 23.3 
Penobscot 1 0.7 0 0.0 20 13.4 19 12.8 0 0.0 14 9.4 
Piscataquis 0 0.0 0 0.0 2 11.9 6 35.6 0 0.0 1 5.9 
Sagadahoc 1 2.8 1 2.8 8 22.2 5 13.9 0 0.0 12 33.3 
Somerset 0 0.0 0 0.0 7 13.8 8 15.7 1 2.0 13 25.5 
Waldo 0 0.0 0 0.0 0 0.0 6 15.6 0 0.0 7 18.2 
Washington 0 0.0 0 0.0 1 3.1 0 0.0 0 0.0 5 15.7 
York 5 2.5 2 1.0 17 8.4 7 3.5 1 0.5 15 7.4 
Maine Total 17 1.3 5 0.4 148 11.3 93 7.1 4 0.3 223 17.0 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2010 
 Haemophilus 
influenzae, invasive 
Hemolytic uremic 
syndrome 
Hepatitis A Hepatitis B, acute Hepatitis B, 
chronic 
Legionellosis 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 2 1.9 1 0.9 0 0.0 0 0.0 20 18.8 3 2.8 
Aroostook 2 2.8 0 0.0 0 0.0 1 1.4 4 5.6 0 0.0 
Cumberland 0 0.0 0 0.0 0 0.0 2 0.7 43 15.5 1 0.4 
Franklin 1 3.4 0 0.0 0 0.0 0 0.0 1 3.4 1 3.4 
Hancock 1 1.9 0 0.0 1 1.9 1 1.9 0 0.0 1 1.9 
Kennebec 1 0.8 0 0.0 0 0.0 2 1.7 3 2.5 1 0.8 
Knox 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 2.5 
Lincoln 1 2.9 0 0.0 0 0.0 0 0.0 2 5.8 1 2.9 
Oxford 1 1.8 0 0.0 0 0.0 1 1.8 2 3.6 0 0.0 
Penobscot 1 0.7 0 0.0 1 0.7 3 2.0 3 2.0 1 0.7 
Piscataquis 1 5.9 0 0.0 0 0.0 1 5.9 0 0.0 0 0.0 
Sagadahoc 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
Somerset 1 2.0 0 0.0 0 0.0 0 0.0 5 9.8 0 0.0 
Waldo 0 0.0 0 0.0 4 10.4 0 0.0 0 0.0 1 2.6 
Washington 0 0.0 0 0.0 1 3.1 1 3.1 1 3.1 0 0.0 
York 1 0.5 0 0.0 0 0.0 1 0.5 17 8.4 1 0.5 
Maine Total 13 1.0 1 0.1 7 0.5 13 1.0 101 7.7 12 0.9 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2010 
 Listeriosis Lyme Disease Malaria Meningococcal 
invasive disease 
MRSA, invasive Mumps 
County No. Rate No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 0 0.0 38 35.7 1 0.9 0 0.0 2 1.9 1 0.9 
Aroostook 1 1.4 4 5.6 0 0.0 0 0.0 5 7.0 0 0.0 
Cumberland 0 0.0 180 65.1 3 1.1 1 0.4 25 9.0 0 0.0 
Franklin 0 0.0 19 64.1 0 0.0 0 0.0 3 10.1 0 0.0 
Hancock 0 0.0 28 52.6 1 1.9 1 1.9 0 0.0 0 0.0 
Kennebec 0 0.0 89 73.6 0 0.0 1 0.8 16 13.2 0 0.0 
Knox 0 0.0 65 160.3 1 2.5 0 0.0 3 7.4 1 2.5 
Lincoln 0 0.0 38 110.5 0 0.0 0 0.0 7 20.4 0 0.0 
Oxford 0 0.0 15 26.8 0 0.0 1 1.8 6 10.7 0 0.0 
Penobscot 0 0.0 11 7.4 0 0.0 0 0.0 0 0.0 0 0.0 
Piscataquis 0 0.0 1 5.9 0 0.0 0 0.0 0 0.0 0 0.0 
Sagadahoc 0 0.0 45 124.9 0 0.0 0 0.0 5 13.9 0 0.0 
Somerset 0 0.0 7 13.8 0 0.0 0 0.0 6 11.8 0 0.0 
Waldo 0 0.0 26 67.8 0 0.0 1 2.6 2 5.2 0 0.0 
Washington 0 0.0 8 25.1 0 0.0 0 0.0 1 3.1 0 0.0 
York 0 0.0 177 87.8 0 0.0 0 0.0 9 4.5 0 0.0 
Maine Total 1 0.1 751 57.2 6 0.5 5 0.4 90 6.9 2 0.2 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2010 
 Pertussis Rabies, animal Salmonellosis Shiga toxin 
producing E. coli 
Shigellosis 
County No. Rate No. Rate No. Rate No. Rate No. No. 
Androscoggin 1 0.9 10  4 3.8 3 2.8 0 0.0 
Aroostook 1 1.4 0  11 15.5 2 2.8 1 1.4 
Cumberland 14 5.1 15  34 12.3 1 0.4 3 1.1 
Franklin 2 6.7 0  1 3.4 1 3.4 0 0.0 
Hancock 5 9.4 1  7 13.1 1 1.9 0 0.0 
Kennebec 1 0.8 12  7 5.8 0 0.0 1 0.8 
Knox 4 9.9 2  3 7.4 0 0.0 0 0.0 
Lincoln 2 5.8 3  4 11.6 0 0.0 1 2.9 
Oxford 1 1.8 5  5 8.9 2 3.6 0 0.0 
Penobscot 18 12.1 3  18 12.1 5 3.4 0 0.0 
Piscataquis 0 0.0 0  2 11.9 0 0.0 0 0.0 
Sagadahoc 1 2.8 1  5 13.9 3 8.3 0 0.0 
Somerset 0 0.0 4  7 13.8 0 0.0 0 0.0 
Waldo 1 2.6 0  3 7.8 0 0.0 0 0.0 
Washington 1 3.1 0  1 3.1 0 0.0 0 0.0 
York 1 0.5 6  21 10.4 3 1.5 2 1.0 
Maine Total 53 4.0 62  133 10.1 21 1.6 8 0.6 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by County, Maine, 2010 
 Streptococcus, 
invasive Group A 
Streptococcus 
pneumoniae, invasive 
Tuberculosis Varicella 
(Chickenpox) 
Vibriosis 
County No. Rate No. Rate No. Rate No. Rate No. Rate 
Androscoggin 4 3.8 18 16.9 2 1.9 13 12.2 0 0.0 
Aroostook 0 0.0 5 7.0 0 0.0 17 24.0 0 0.0 
Cumberland 10 3.6 38 13.7 6 2.2 61 22.1 1 0.4 
Franklin 3 10.1 3 10.1 0 0.0 6 20.2 1 3.4 
Hancock 1 1.9 1 1.9 0 0.0 25 46.9 0 0.0 
Kennebec 7 5.8 21 17.4 0 0.0 5 4.1 1 0.8 
Knox 0 0.0 0 0.0 0 0.0 7 17.3 0 0.0 
Lincoln 2 5.8 10 29.1 0 0.0 4 11.6 0 0.0 
Oxford 6 10.7 3 5.4 0 0.0 11 19.7 0 0.0 
Penobscot 4 2.7 1 0.7 0 0.0 25 16.8 0 0.0 
Piscataquis 0 0.0 2 11.9 0 0.0 3 17.8 0 0.0 
Sagadahoc 0 0.0 1 2.8 0 0.0 18 50.0 0 0.0 
Somerset 4 7.9 6 11.8 0 0.0 11 21.6 0 0.0 
Waldo 2 5.2 2 5.2 0 0.0 11 28.7 0 0.0 
Washington 0 0.0 0 0.0 0 0.0 3 9.4 0 0.0 
York 4 2.0 19 9.4 0 0.0 27 13.4 2 1.0 
Maine Total 47 3.6 130 9.9 8 0.6 247 18.8 5 0.4 
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Reportable HIV/STDs, Number of Cases and Rate per 100,000 Persons by County, Maine, 2010 
 Chlamydia Gonorrhea Syphilis, Primary and 
Secondary* 
HIV 
County No. Rate No. Rate No. Rate No. Rate 
Androscoggin 289 271.8 51 48.0 0 0.0 7 6.6 
Aroostook 128 180.3 6 8.5 2 2.8 0 0.0 
Cumberland 629 227.5 55 19.9 22 8.0 23 8.3 
Franklin 42 141.7 1 3.4 0 0.0 0 0.0 
Hancock 84 157.7 5 9.4 0 0.0 0 0.0 
Kennebec 295 243.9 9 7.4 2 1.7 4 3.3 
Knox 73 180.0 1 2.5 0 0.0 6 14.8 
Lincoln 47 136.7 2 5.8 0 0.0 1 2.9 
Oxford 74 132.4 1 1.8 0 0.0 3 5.4 
Penobscot 302 203.0 17 11.4 1 0.7 1 0.7 
Piscataquis 18 106.7 0 0.0 0 0.0 0 0.0 
Sagadahoc 66 183.2 6 16.7 0 0.0 1 2.8 
Somerset 101 198.4 0 0.0 0 0.0 1 2.0 
Waldo 58 151.2 1 2.6 2 5.2 2 5.2 
Washington 48 150.3 2 6.3 0 0.0 0 0.0 
York 332 164.7 5 2.5 9 4.5 10 5.0 
Maine Total 2586 197.0 162 12.3 39 3.0 59 4.5 
*County unknown for one case 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District, Maine, 2010 
Condition Aroostook Central Cumberland Downeast Mid Coast 
No. Rate No. Rate No. Rate No. Rate No. Rate 
Anaplasmosis 0 0.0 0 0.0 3 1.1 0 0.0 7 4.7 
Babesiosis 0 0.0 0 0.0 0 0.0 0 0.0 3 2.0 
Campylobacteriosis 9 12.7 22 12.8 34 12.3 9 10.6 15 10.0 
Chlamydia 128 180.3 396 230.4 629 227.5 132 154.9 244 163.4 
Cryptosporidosis 7 9.9 21 12.2 5 1.8 6 7.0 18 12.1 
Ehrlichia chaffeensis 0 0.0 1 0.6 0 0.0 0 0.0 1 0.7 
Giardiasis 2 2.8 28 16.3 82 29.7 21 24.6 25 16.7 
Gonorrhea 6 8.5 9 5.2 55 19.9 7 8.2 10 6.7 
Haemophilus influenzae, invasive 2 2.8 2 1.2 0 0.0 1 1.2 1 0.7 
Hemolytic uremic syndrome 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
HIV 0 0.0 5 2.9 23 8.3 0 0.0 10 6.7 
Hepatitis A 0 0.0 0 0.0 0 0.0 2 2.3 4 2.7 
Hepatitis B, acute 1 1.4 2 1.2 2 0.7 2 2.3 0 0.0 
Hepatitis B, chronic 4 5.6 8 4.7 43 15.5 1 1.2 2 1.3 
Legionellosis 0 0.0 1 0.6 1 0.4 1 1.2 3 2.0 
Listeriosis 1 1.4 0 0.0 0 0.0 0 0.0 0 0.0 
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 Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District, Maine, 2010 
Condition Penquis Western York State 
No. Rate No. Rate No. Rate No. Rate 
Anaplasmosis 1 0.6 1 0.5 5 2.5 17 1.3 
Babesiosis 0 0.0 0 0.0 2 1.0 5 0.4 
Campylobacteriosis 22 13.3 20 10.4 17 8.4 148 11.3 
Chlamydia 320 193.2 405 211.1 332 164.7 2586 197.0 
Cryptosporidosis 25 15.1 4 2.1 7 3.5 93 7.1 
Ehrlichia chaffeensis 0 0.0 1 0.5 1 0.5 4 0.3 
Giardiasis 15 9.1 35 18.2 15 7.4 223 17.0 
Gonorrhea 17 10.3 53 27.6 5 2.5 162 12.3 
Haemophilus influenzae, invasvie 2 1.2 4 2.1 1 0.5 13 1.0 
Hemolytic uremic syndrome 0 0.0 1 0.5 0 0.0 1 0.1 
HIV 1 0.6 10 5.2 10 5.0 59 4.5 
Hepatitis A 1 0.6 0 0.0 0 0.0 7 0.5 
Hepatitis B, acute 4 2.4 1 0.5 1 0.5 13 1.0 
Hepatitis B, chronic 3 1.8 23 12.0 17 8.4 101 7.7 
Legionellosis 1 0.6 4 2.1 1 0.5 12 0.9 
Listeriosis 0 0.0 0 0.0 0 0.0 1 0.1 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District, Maine, 2010 
Condition Aroostook Central Cumberland Downeast Mid Coast 
No. Rate No. Rate No. Rate No. Rate No. Rate 
Lyme Disease 4 5.6 96 55.9 180 65.1 36 42.3 174 116.5 
Meningococcal invasive disease 0 0.0 1 0.6 1 0.4 1 1.2 1 0.7 
MRSA, invasive 5 7.0 22 12.8 25 9.0 1 1.2 17 11.4 
Mumps 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
Pertussis 1 1.4 1 0.6 14 5.1 6 7.0 8 5.4 
Rabies, animal 0  16  15  1  6  
Salmonellosis 11 15.5 14 8.1 34 12.3 8 9.4 15 10.0 
Shiga toxin producing E. coli 2 2.8 0 0.0 1 0.4 1 1.2 3 2.0 
Shigellosis 1 1.4 1 0.6 3 1.1 0 0.0 1 0.7 
Streptococcus, invasive Group A 0 0.0 11 6.4 10 3.6 1 1.2 4 2.7 
Streptococcus pneumoniae, 
invasive  5 7.0 27 15.7 38 13.7 1 1.2 13 8.7 
Syphilis *county missing for one 2 2.8 2 1.2 22 8.0 0 0.0 2 1.3 
Tuberculosis 0 0.0 0 0.0 6 2.2 0 0.0 0 0.0 
Varicella (chickenpox) 17 24.0 16 9.3 61 22.1 28 32.9 40 26.8 
Vibriosis 0 0.0 1 0.6 1 0.4 0 0.0 0 0.0 
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Reportable Conditions, Number of Confirmed and Probable Cases and Rate per 100,000 Persons by District, Maine, 2010 
Condition Penquis Western York State 
No. Rate No. Rate No. Rate No. Rate 
Lyme Disease 12 7.2 72 37.5 177 87.8 751 57.2 
Meningococcal invasive disease 0 0.0 1 0.5 0 0.0 5 0.4 
MRSA, invasive 0 0.0 11 5.7 9 4.5 90 6.9 
Mumps 0 0.0 1 0.5 0 0.0 2 0.2 
Pertussis 18 10.9 4 2.1 1 0.5 53 4.0 
Rabies, animal 3  15  6  62  
Salmonellosis 20 12.1 10 5.2 21 10.4 133 10.1 
Shiga toxin producing E. coli 5 3.0 6 3.1 3 1.5 21 1.6 
Shigellosis 0 0.0 0 0.0 2 1.0 8 0.6 
Streptococcus, invasive Group A 4 2.4 13 6.8 4 2.0 47 3.6 
Streptococcus pneumoniae, 
invasive  3 1.8 24 12.5 19 9.4 130 9.9 
Syphilis *county missing for one 1 0.6 0 0.0 9 4.5 39 3.0 
Tuberculosis 0 0.0 2 1.0 0 0.0 8 0.6 
Varicella 28 16.9 30 15.6 27 13.4 247 18.8 
Vibriosis 0 0.0 1 0.5 2 1.0 5 0.4 
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Anaplasmosis 
2010 Case Total 17 
Maine Rate 1.3 per 100,000 
U.S. rate (2009) 0.4 per 100,000 
Anaplasmosis Incidence, Maine and US, 
2006-2010
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Anaplasmosis is a disease caused by the 
b a c t e r i u m ,  A n a p l a s m a 
phagocytophilium.   Anaplasmosis was 
p r e v i ou s l y  known  a s  human 
granulocytic ehrlichiosis (HGE) or 
human granulocytic anaplasmosis 
(HGA).   
 
Signs and symptoms of anaplasmosis 
include:  fever, headache, malaise, and 
body aches.   Anaplasmosis is 
transmitted to a person by the bite of an 
infected deer tick (Ixodes scapularis), 
one of the most common ticks in Maine. 
 
• Case total of 17 represents a  increase 
from 15 cases in 2009 
• The 2005-2009 median number of 
cases per year was 10 
• Median age was 60 years 
• Age range was 17 to 90 years 
• Cases were 53% female and 47% 
male 
• Greatest number of cases occurred 
during the spring and early summer 
months 
 
The best way to prevent infection is to 
take measures to protect against tick 
bites.  Checking for ticks after visiting a 
tick infested area is an important way to 
reduce the risk of contracting 
anaplasmosis.  Also, using EPA 
approved repellents such as DEET or 
permethrin applied properly according 
to the directions, is a good way to 
protect against ticks. If an engorged tick 
is found, it should be safely removed 
and saved for identification.  
 
For more information about submitting 
a  t ick for  identif ication visi t 
www.mmcri.org/lyme.    
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Babesiosis 
2010 Case Total 5 
Maine Rate 0.4 per 100,000 
U.S. rate (2009) Not reportable 
Babesiosis Incidence, Maine, 2006-2010
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Babesiosis is caused by a parasite that 
may be carried by ticks.  Many 
individuals that get the disease do not 
have symptoms.  Serious symptoms can 
occur, especially in persons who are 
immunosuppressed, those without a 
spleen, or people who are co-infected 
with Lyme disease.  Babesia may also 
occur after a blood transfusion from an 
infected donor. 
 
Common symptoms include extreme 
fatigue, aches, fever, chills, sweating, 
dark urine, and possibly anemia.   
 
• Case total of 5 represents an increase 
from 3 cases in 2009 
• The 2005-2009 median number of 
cases was 11 
• Median age was 65 years 
• Age range was 31 to 74 years 
• Cases were 60% female and 40% 
male 
• All cases occurred during the summer 
months 
 
The best way to prevent infection is to 
take measures to protect against tick 
bites.  Checking for ticks after visiting a 
tick infested area is an important way to 
reduce the risk of contracting 
babesiosis.  Also, using EPA approved 
repellents such as DEET or permethrin 
applied properly according to the 
directions, is a good way to protect 
against ticks.  If an engorged tick is 
found, it should be safely removed and 
saved for identification. 
 
For more information about submitting 
a  t ick for  identif ication visi t 
www.mmcri.org/lyme.    
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Campylobacteriosis 
2010 Case Total 148 
Maine Rate 11.3 per 100,000 
U.S. rate (2009) Not reportable 
Campylobacteriosis Incidence, Maine, 
2006-2010
0
2
4
6
8
10
12
14
2006 2007 2008 2009 2010
Year
C
a
s
e
s
 p
e
r 
1
0
0
,0
0
0
Campylobacteriosis by Age and Gender, Maine, 
2010
0
2
4
6
8
10
12
14
16
18
0-4 5-14 15-24 25-34 35-44 45-54 55-64 65+
Age group
C
a
s
e
s
Male Female
Campylobacteriosis by Month of Report, Maine, 
2010
0
5
10
15
20
Ja
n
Fe
b
M
ar A
pr
M
ay Ju
n
Ju
l
A
ug
S
ep O
ct
N
ov
D
ec
Month
C
a
s
e
s
Campylobacteriosis is one of the most 
common infectious diseases causing 
diarrhea in the United States.  
Symptoms include diarrhea, cramping, 
abdominal pain and fever. Most people 
recover within 5 to 10 days. Very rarely 
some individuals develop a disease 
called Guillain-Barre syndrome which 
causes temporary paralysis and requires 
intensive care hospitalization.  
 
Many cases are associated with 
handling raw poultry or eating 
undercooked poultry meat. It is also 
possible for other raw foods, such as 
vegetables or salad, to be contaminated 
if the same cutting board or utensil is 
used for both food items and not 
cleaned between preparations.  
 
• Case total of 148 represents a 
decrease from 171 cases in 2009 
• The 2005-2009 median number of 
cases was 151   
• Median age was 45 years 
• Age range was 18 days to 86 years 
• Cases were 49% female and 51% 
male 
• Highest rates in Cumberland, 
Penobscot and York counties 
• Greatest number of cases occurred 
during the summer months and early 
fall  
 
To prevent illness, individuals should 
cook poultry and other meats properly, 
avoid consuming untreated water, raw 
mi lk and  milk products ,  and 
unpasteurized juice. 
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Chlamydia 
2010 Case Total 2,586 
Maine Rate 197  per 100,000 
U.S. rate (2009) 409.2 per 100,000 
Chlamydia Incidence, Maine and US, 2006-2010
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Chlamydia is a sexually transmitted 
disease (STD) caused by the bacterium 
Chlamydia trachomatis.  Chlamydia is 
known as a “silent” disease, as three 
quarters (75%) of women and half 
(50%) of men will have no symptoms.  
Common symptoms for women include 
vaginal discharge or a burning feeling 
with urination and for men include 
discharge from his penis and a burning 
feeling during urination.  
 
If chlamydia is not treated, the infection  
may cause serious damage to the 
reproductive system, including 
infertility.  Chlamydia can be passed to 
a child during birth.  People with 
chlamydia can more easily contract HIV 
from someone else  or transmit HIV to 
others if they are infected with both.    
   
• Chlamydia is the most frequently 
reported STD in Maine 
• The 5 year trend shows that three 
women were diagnosed for every 
one man 
• 70% of infections were in persons 
15-24 years old 
 
Chlamydia can be prevented by the use 
of latex or polyurethane condoms and 
dental dams during anal, vaginal, and 
oral sex. Efforts to prevent the spread of 
chlamydia are primarily through 
prioritized follow up activities for new 
diagnosis,  and the Infertility Prevention 
Project, a federal CDC sponsored 
initiative, that targets testing and 
treatment for females 15-24 years old 
and their partners.  Currently free 
testing for females 15-24 is available at 
Family Planning and  Planned 
Parenthood sites, and at the three STD 
cl inics  (Bangor ,  Por t land and 
Lewiston).  
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Cryptosporidiosis 
2010 Case Total 93 
Maine Rate 7.1 per 100,000 
U.S. rate (2009) 2.5 per 100,000 
Cryptosporidiosis Incidence, Maine and US, 2006-
2010
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Cryptosporidiosis is an infection most 
frequently associated with contaminated 
water. The disease is caused by a 
parasite that lives in the intestines of 
animals and infected humans.  Feces 
containing the parasite may contaminate 
the ground or water sources.  The 
parasite may live for long periods of 
time in the environment due to a 
protective outer covering. It is resistant 
to many chlorine-based disinfectants, 
increasing the risk of transmission in 
swimming pool settings. 
 
Symptoms include diarrhea, abdominal 
cramping, malaise and vomiting. 
 
• Case total of 93 represents an 
increase from 67 cases in 2009 
• The 2005-2009 median number of 
cases per year was 52  
• Median age was 30 years 
• Age range was 7 months to 93 years 
• Cases were 57% female and 43% 
male 
• Highest incidence was in Penobscot, 
Kennebec, and Somerset counties 
• Greatest number of cases occurred 
during the summer months  
 
Preventive measures include practicing 
good hand hygiene around farm animals 
and discouraging any persons from 
swimming when they have diarrheal 
illness. 
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Ehrlichiosis 
2010 Case Total 4 
Maine Rate 0.3 per 100,000 
U.S. rate (2009) 0.3 per 100,000 
Ehrlichiosis Incidence, Maine and US, 
2006-2010
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Ehrlichiosis is a disease caused by the 
bacterium Ehrlichia chaffeensis which 
infects white blood cells (monocytes).  
Ehrlichia chaffeensis was previously 
known as human monocytic ehrlichiosis 
(HME).   
 
Signs and symptoms of ehrlichiosis 
include:  fever, headache, nausea, and 
body aches.  Ehrlichiosis is transmitted 
to a person through the bite of an 
infected lone star tick (Amblyomma 
americanum), an uncommon tick in 
Maine.    
 
• Case total of 4 probable cases 
represents an increase from 1 
probable case in 2009 
• The 2005-2009 median number of 
cases per year was 1 
 
The best way to prevent infection is to 
take measures to protect against tick 
bites.  Checking for ticks after visiting a 
tick infested area is an important way to 
reduce the risk of contracting 
ehrlichiosis.  Also, using EPA approved 
repellents such as DEET or permethrin 
applied properly according to the 
directions, is a good way to protect  
against ticks.  If an engorged tick is 
found, it should be safely removed and 
saved for identification. 
 
For more information about submitting 
a tick for identification visit 
www.mmcri.org/lyme.    
*onset date missing for one case 
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Giardiasis 
2010 Case Total 223 
Maine Rate 17 per 100,000 
U.S. rate (2009) 6.3 per 100,000 
Giardiasis Incidence, Maine and US, 2006-2010
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Giardiasis is sometimes known as 
“beaver fever” because beavers (as well 
as dogs, cats, horses and cows) are 
major reservoirs for the parasite 
(Giardia lamblia) that causes the 
infection. The parasite lives in the 
intestines of infected humans and 
animals and when expelled through the 
feces can contaminate water and ground 
surfaces. The animal feces can infect 
ponds and streams and if hikers or 
others drink water in the wild without 
proper treatment they may become 
infected. Young children in child care or 
pool settings who are prone to sucking 
on toys or swallowing water are also at 
higher risk. 
 
• Case total of 223 represents the same 
number of cases as 2009 
• The 2005-2009 median number of 
cases per year was 197  
• Median age was 35 years 
• Age range was 9 months to 90 years 
• Cases were 50% female and 50% 
male 
• Highest incidence was in Cumberland 
and Androscoggin counties 
• Greatest number of cases occurred 
during the late summer  and fall 
months 
 
Individuals can prevent this illness by 
not drinking from untreated water 
sources, such as streams and lakes.  
Increased attention to proper sanitation 
and hygiene in public water recreational 
facilities can help to reduce the 
transmission of Giardia. 
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Gonorrhea 
2010 Case Total 162 
Maine Rate 12.3  per 100,000 
U.S. rate (2009) 99.1 per 100,000 
Gonorrhea Incidence, Maine and US, 2006-2010
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Gonorrhea is a sexually transmitted 
disease (STD) caused by the bacterium 
Neisseria gonorrhoeae that grows and 
multiplies in warm, moist areas.  
Gonorrhea can be spread through 
contact with the vagina, penis, mouth or 
anus.  Gonorrhea can also spread from a 
mother to her baby during childbirth.  
Gonorrhea does not always cause 
symptoms.  Men may feel a burning 
sensation while urinating, or have  
discharge from their penis.  Women 
might feel pain with urination, or notice 
discharge.   
 
Gonorrhea is dangerous if untreated.  In 
women, gonorrhea is a common cause 
of pelvic inflammatory disease, which 
can lead to chronic pain and infertility.  
In  men,  gonorrhea can cause 
epididymitis, causing painful testicles 
and  infertility.  People infected with 
HIV are more likely to contract 
gonorrhea and to transmit HIV if they 
are also infected with gonorrhea .     
 
• Case total of 162 represents an 
increase from 143 cases in 2009  
• Highest incidence was in the 20-24 
year age group  (36% of female cases 
and 38% of male cases)  
• Cases were 47% female and 53% 
male 
 
Gonnorhea can be prevented by using 
latex or polyurethane condoms and 
dental dams during anal, vaginal, and 
oral sex. Prevention efforts include 
treatment verification and case 
investigation activities, such as partner 
follow-up for all new  infections. State 
sponsored testing through the Infertility 
Prevention Project uses a combination 
gonorrhea and chlamydia test targeting 
females 15-24 years old and their 
partners.    
Gonorrhea by Month, Maine, 2010
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Group A Streptococcal 
Disease 
2010 Case Total 47 
Maine Rate 3.6 per 100,000 
U.S. rate (2009) 1.7 per 100,000 
Invasive GAS Incidence, Maine and US 2006-2010
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Group A Streptococcus (GAS) is a 
bacterium often found in the throat and on 
the skin that can cause either no 
symptoms or mild symptoms such as 
pharyngitis (strep throat), cellulitis (soft 
tissue infection) or impetigo (skin 
dermatitis).  When the bacteria enter 
deeper tissues and the blood stream, GAS 
can cause severe or life-threatening 
conditions. 
 
Necrotizing fasciitis, a condition that 
progressively destroys skin, fat and 
muscles, can be caused by GAS.  Another 
example of an invasive GAS disease is 
Streptococcal Toxic Shock Syndrome 
(STSS), a rapid drop of blood pressure 
that causes organ failure. 
 
• Case total of 47 represents an increase 
from 21 cases in 2009 
• The 2005-2009 median number of 
cases per year was 21  
• Median age was 62 years 
• Age range was 9 months to 95 years 
• Cases were 66% female and 34% male 
• 21 (45%) of 47 cases were also 
diagnosed with STSS 
 
Control and prevention strategies may 
include targeted chemoprophylaxis for 
high risk household contacts of confirmed 
cases, such as those who are 65 and older 
or those who have other specified risk 
factors (HIV infection, diabetes, 
malignancy, injecting drug use, or cardiac 
diseases). 
28
Haemophilus influenzae 
2010 Case Total 13 
Maine Rate 1.0 per 100,000 
U.S. rate (2009) 1.0 per 100,000 
Haemophilus influenzae  Incidence, Maine and 
US, 2006-2010
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Haemophilus influenzae disease is 
caused by the Haemophilus influenzae 
bacterium.  A specific type called H. 
influenzae serotype B (Hib), was once 
the most common cause of bacterial 
meningitis in children.  Due to 
widespread use of Hib vaccine, few 
cases in children less than 5 years old 
are reported each year.   
 
The bacteria are spread from person to 
person, through airborne droplets, when 
an infected person coughs or sneezes.  
H. influenzae can cause severe illnesses 
such as meningitis, bacteremia, 
pneumonia and septic arthritis. 
 
• Case total of 13 represents a decrease 
from 21 cases in 2009 
• The 2005-2009 median number of 
cases per year was 21  
• Median age was 73 years 
• Age range was 22 years to 90 years 
• Cases were 46% female and 54% 
male 
• No cases of Hib in children aged < 15 
years were reported 
 
Haemophilus influenzae serotype b 
(Hib) may be prevented in children 
through vaccination.  Vaccination is 
recommended for all children at ages 2, 
4 and 6 months or at 2 and 4 months 
depending on the type of vaccine 
available.  An additional booster dose is 
given at 12-15 months of age with either 
type of vaccine. 
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Hepatitis A 
2010 Case Total 7 
Maine Rate 0.5 per 100,000 
U.S. rate (2009) 0.7 per 100,000 
Hepatitis A Incidence, Maine and US, 2006-2010
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Hepatitis A is a liver disease caused by 
hepatitis A virus. The virus is spread 
from person to person by putting 
something in the mouth that has been 
contaminated with the stool of a person 
with hepatitis A.  Poor handwashing by 
persons with infection increases the risk 
of transmission. The virus spreads more 
easily in areas where sanitary conditions 
and personal hygiene practices are poor.  
Most infections result from exposure 
during international travel, or contact 
with a household member or a sexual 
partner who has hepatitis A. 
 
Onset of symptoms is usually abrupt 
with fever, malaise, anorexia, nausea 
and abdominal discomfort followed by 
jaundice a few days later. Children are 
often asymptomatic. Upon recovery, a 
person is immune to hepatitis A.  
 
• Case total of 7 represents an increase 
from 1 case in 2009 
• The 2005-2009 median number of 
cases per year was 8 
 
Washing hands after using the 
bathroom, changing a diaper, or before 
preparing or eating food can help 
prevent infection. Hepatitis A can be 
prevented through vaccination and use 
of immune globulin. The vaccine is 
recommended for all children at 12 
months of age and for persons who are 
more likely to get hepatitis A or become 
seriously ill if they get hepatitis A.   
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Hepatitis B, acute 
2010 Case Total 13 
Maine Rate 1.0 per 100,000 
U.S. rate (2009) 1.1 per 100,000 
Hepatitis B Incidence, Maine and US, 2006-2010
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Hepatitis B is a liver disease caused by 
the hepatitis B virus. Acute Hepatitis B 
infection is a short-term illness that 
occurs within the first six months after 
someone is exposed to the virus. In 
some cases, acute infection can lead to 
chronic infection. 
 
Hepatitis B can be transmitted through 
exposure to blood from an infected 
person (needle sticks and other sharps 
exposures, sharing hypodermic syringes 
for drug injection), through sexual 
contact with an infected person, and 
from an infected mother to her child 
during childbirth.  Sexual transmission 
is especially common among men who 
have sex with men.  
 
Symptoms include anorexia, abdominal 
discomfort, nausea and vomiting 
followed by jaundice. Many young 
children do not develop symptoms. 
 
• Case total of 13 represents a decrease 
from 15 cases in 2009 
• The 2005-2009 median number of 
cases per year was 15  
• Median age was 44 years 
• Age range was 27 to 72 years 
• Cases were 8% female and 92% male 
 
A vaccine is available to prevent HBV 
and Maine CDC’s goal is to provide 
universal childhood immunization by 
vaccinating all newborn infants prior to 
hospital discharge and completing the 
hepatitis B series by the time the child 
reaches 18 months of age. Hepatitis B 
can also be prevented by not sharing 
needles and other drug injecting 
equipment, using sterile needles and 
syringes, and using condoms. 
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Hepatitis B, chronic 
2010 Case Total 101 
Maine Rate 7.7 per 100,000 
U.S. rate (2009) Not available 
Hepatitis B Incidence, Maine and US, 2006-2010
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Chronic hepatitis B virus infection is a 
long-term illness that occurs when the 
hepatitis B virus remains in a person’s 
body.  
 
Chronic hepatitis B is a serious disease 
that can result in long-term health 
problems, such as cirrhosis (scarring) of 
the liver, liver cancer, liver failure, and 
even death. Many people do not have 
symptoms and may not know they are 
infected, but can still spread the disease 
to others. 
 
Hepatitis B can be transmitted through 
exposure to blood from an infected 
person (needle sticks and other sharps 
exposures, sharing hypodermic syringes 
for drug injection), through sexual 
contact with an infected person, and 
from an infected mother to her child 
during childbirth.  Sexual transmission 
also occurs among men who have sex 
with men.  
 
• Case total of 101 represents a 
decrease from 126 cases in 2009 
• Median age was 41 years 
• Age range was 9 to 79 years 
• Cases were 28% female and 72% 
male 
 
Prevention, education, evaluation and 
surveillance continue to be the focus for 
Maine CDC.  Maine CDC’s goal is to 
p r o v i d e  u n i v e r s a l  c h i l d ho od 
immunization by vaccinating all 
newborn infants prior to hospital 
discharge and completing the hepatitis 
B series by the time the child reaches 18 
months of age. Hepatitis B can also be 
prevented by not sharing needles and 
other drug injecting equipment, using 
sterile needles and syringes, and using 
condoms. 
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Hepatitis C 
2010 Case Total 1142 
Maine Rate 87.0 per 100,000 
U.S. rate (2009) N/A 
Reported Cases of Chronic Hepatitis C, Maine, 
2006-2010
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Hepatitis C is a liver disease caused by 
hepatitis C virus. It can range in severity 
from a mild illness lasting a few weeks 
to a serious, lifelong illness or even 
death. Hepatitis C virus (HCV) is spread 
when blood from a person infected with 
the HCV enters the body of someone 
who is not infected. Many people 
become infected with the HCV virus by 
sharing needles or other injection drug 
equipment. 
 
Most people with chronic HCV do not 
have any symptoms. In many cases, 
symptoms only appear when liver 
problems develop. In persons without 
symptoms, HCV is often detected 
during routine blood tests to measure 
liver function and liver enzyme level.  
 
A hepatitis C positive report is defined 
as the presence of any positive serologic 
marker for hepatitis C infection.  
 
• Case total of 1142 represents a  
    decrease from 2009 
• Age range was 2 to 83 years 
• Highest number of cases reported 
among people 45-54 years old 
• Cases were 64% male and 36%  
    female, with one person unidentified 
• Two cases of acute hepatitis C 
infection were reported 
 
People with HCV should be monitored 
regularly by an experienced healthcare 
provider. They should avoid alcohol and  
check with a health professional before 
t aking any prescr ipt ion  p i l l s , 
supplements, or over-the-counter 
medications, as these can potentially 
damage the liver. Vaccination against 
hepatitis A and hepatitis B is also 
recommended. 
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HIV* 
2010 Case Total 59 
Maine Rate 4.3 per 100,000 
U.S. rate (2009) 17.4 per 100,000 
Newly Identified HIV Diagnoses, Maine and 
US**, 2006-2010
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Human immunodeficiency virus (HIV) 
is a virus that is responsible for HIV 
disease and acquired immuno-
deficiency syndrome (AIDS). AIDS 
typically presents as the late clinical 
stage of HIV infection. HIV is 
transmitted  from person to person 
through unprotected penile-vaginal or 
penile–anal intercourse with an infected 
person; the use of HIV contaminated 
needles and syringes; from infected 
mother to infant during pregnancy, 
delivery, or breast-feeding; and 
transfusion of infected blood or its 
components. In Maine, the most 
common mode of HIV transmission is 
through unprotected penile-anal 
intercourse among men. Other common 
transmission modes in Maine include 
non-prescription injection drug use and 
heterosexual partner at high risk for 
HIV infection.   
 
• Case total of 59 represents an 
increase from 57 cases in 2009  
• The 2005-2009 median number of 
cases per year was 52 
• Age range was 18-69 years  
• Majority of cases were male (83%) 
• 59% of cases reported risk factor of 
males who have sex with other males 
• Highest incidence was in people 40-
49 years old (36%) 
  
HIV transmission can be prevented by 
the use of latex or polyurethane 
condoms and dental dams during anal, 
vaginal, and oral sex.  It is equally 
important to always use clean needles 
and injection equipment when injecting 
any substance.  HIV testing, counseling, 
and referral services are offered by 
various agencies and programs 
dedicated to HIV prevention and 
treatment in Maine.   
*Includes all newly identified HIV infections, including those simultaneously diagnosed as new AIDS cases.  
**Based on reports from 40 reporting states. 
Mode of Transmission New  
Diagnoses 
Men who have sex with men (MSM) 35 
Injection drug users (IDU) 3 
MSM/IDU 3 
Heterosexual contact with at-risk partners 3 
Heterosexual, no at-risk partners disclosed 13 
Undetermined 2 
Received contaminated  blood products 0 
Child born to mother with HIV 0 
Reported Transmission Risk Factors Among Persons 
Diagnosed with HIV, 2010 
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Legionellosis 
2010 Case Total 12 
Maine Rate 0.9 per 100,000 
U.S. rate (2009) 1.2 per 100,000 
Legionellosis Incidence, Maine and US, 
2006-2010
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Legionellosis (or Legionnaire’s disease) 
is a serious and sometimes fatal form of 
pneumonia. Legionella bacteria are 
widespread in natural, industrial and 
recreational water sources.  The bacteria 
grow best in warm, stagnant water.  
They can be found in creeks and ponds, 
hot and cold water taps, hot water tanks, 
water cooling towers, and condensers of 
large air-conditioning systems.  People 
get legionellosis when they breathe in a 
mist or vapor that is contaminated with 
the bacteria.  Persons at high risk of 
getting legionellosis include those who 
are middle aged or older, smoke, have 
chronic lung disease, or weakened 
immune systems due to cancer, kidney 
failure, diabetes or HIV infection. 
 
Symptoms include high fever, chills, 
muscle aches, headaches, cough and 
pneumonia.  Legionellosis is treatable 
with antibiotics.  
 
• Case total of 12 represents a increase 
from 10 cases in 2009 
• The 2005-2009 median number of 
cases per year was 10 
• Median age was 67 years 
• Age range was 42 to 81 years 
• Cases were 33% female and 67% 
male 
 
P r even t i on  d epends  on  good 
maintenance of possible water sources 
of infection (water tanks, water systems, 
fountains, etc.). This includes regular 
cleaning, disinfecting and applying  
other physical (temperature) or 
chemical measures to minimize growth.  
Applying such controls at hospitals, 
industrial sites, hotels and recreation 
centers will reduce the risk of water 
contamination. 
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Listeriosis 
2010 Case Total 1 
Maine Rate 0.1 per 100,000 
U.S. rate (2009) 0.3 per 100,000 
Listeriosis Incidence, Maine and US, 2006-2010
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Listeriosis is a bacterial illness, caused 
by Listeria monocytogenes. Infection 
may cause sepsis and meningitis.  
Listeriosis is frequently linked to ready-
to-eat meats (such as pate and 
refrigerated smoked seafood), deli 
meats, soft cheeses and raw milk. 
Pregnant women are at highest risk as 
the infection can be acquired during 
pregnancy and transmitted to the fetus.  
Also at risk are the elderly and 
individuals with significant health 
conditions like cancer, diabetes, liver 
disease, immune system problems, or 
multiple medical conditions.  
 
Symptoms include fever, headache, 
nausea, fatigue and disorientation.  
Listeriosis may cause spontaneous 
abortion.  
 
• Case total of 1 represents a decrease 
from 4 cases in 2009 
• The 2005-2009 median number of 
cases per year was 5 cases 
• The one case was hospitalized 
 
Listeria bacteria are able to multiply in 
contaminated foods even during 
refrigeration.  Poultry or meat 
(including hot dogs) should not be 
consumed without following proper 
cooking instructions. Raw milk or foods 
made from raw milk should be avoided.  
Pregnant women and people with 
weakened immune systems should 
avoid eating such foods as ready-to-eat 
meats, hot dogs, soft cheeses, and 
refrigerated smoked seafood. 
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Lyme Disease 
2010 Case Total 751 
Maine Rate 57.2 per 100,000 
U.S. Rate (2009) 12.5 per 100,000 
Lyme Disease Incidence, Maine and US, 
2006-2010
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Lyme disease, Maine’s most common 
vectorborne disease in humans, is 
caused by the bacterium Borrelia 
burgdorferi. The disease is transmitted 
via the bite of an infected deer tick 
(Ixodes scapularis) and symptoms are 
generally visible around 3 days after the 
initial bite. The typical “bulls-eye” rash 
can be followed by fever, headache, 
joint and muscle pain, fatigue, and later, 
arthritis, Bell’s palsy and other cranial 
nerve palsies, meningitis, and carditis.  
 
The case definition for classifying cases 
changed effective January 1, 2008,  and 
included a probable case definition 
which led to a higher case count than 
previous years. 
 
• Case total of 751 represents an 
decrease from 970 cases in 2009 
• The 2005-2009 median number of 
cases per year was 528 
• Median age was 46 years 
• Age range was 1 to 91 years 
• Cases were 47% female and 53% 
male 
• Most cases occurred during summer 
months (48% in June-August) 
• Cases were greatest in York (24%) 
and Cumberland (24%) counties 
 
Although there is no vaccine for Lyme 
disease, risk can be greatly reduced by 
avoiding tick habitats, using EPA 
approved insect repellents (such as 
DEET), wearing long sleeves and pants, 
and checking for ticks after spending 
time in tick habitat. Landscape 
management and control of deer herds 
can also allow communities to better 
protect residents from Lyme disease. 
 
For more information about submitting 
a tick for identification visit 
www.mmcri.org/lyme.    
Lyme Disease by Month of Report, Maine, 2010
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Meningococcal Disease 
2010 Case Total 5 
Maine Rate 0.4 per 100,000 
U.S. rate (2009) 0.3 per 100,000 
Meningococcal Disease Incidence, Maine and 
US, 2006-2010
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Meningococcal disease is an infection 
caused by Neisseria meningitidis, a 
gram-negative diplococcus bacterium. 
Meningococcal disease presents most 
commonly as meningitis and/or 
meningococcemia that may progress 
rapidly to purpura fulminans, shock and 
death. Transmission of meningococcal 
disease most often occurs through direct 
contact with respiratory secretions from 
the nose or throat of a person with the 
infection.  
 
Symptoms include fever, headache, and 
stiff neck for meningitis and rash and 
sepsis for meningococcemia.  The 
symptoms are indistinguishable from 
other pathogens causing  meningitis. 
 
• Case total of 5 represents an increase 
from 4 cases in 2009 
• The 2005-2009 median number of 
cases per year was 6  
• Median age was 2 years 
• Age range was 1 to 94 years 
• Cases were 60% female and 40% 
male 
• Serogroups identified include: B(3), 
Y(1), and unknown(1) 
 
There are at least thirteen known 
Neisseria meningitidis serogroups, and 
there is currently a vaccine available for 
the four serogroups that cause the 
majority of infections (serogroups A, C, 
Y, and W-135). The vaccine is 
recommended for all adolescents, 
college students, military recruits, 
overseas travelers, and any other 
persons at increased risk of infection. 
To prevent the spread of disease, 
chemoprophylaxis is available for 
persons who have close and direct with 
a person with the infection. 
Meningococcal Disease by Age and Gender, 
Maine, 2010
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MRSA, invasive 
2010 Case Total 90 
Maine Rate 6.9 per 100,000 
U.S. rate (2009) Not reportable 
Invasive MRSA Incidence, Maine, 2006-2010
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Since 2008, all cases of invasive 
Methicillin-Resistant Staphylococcus 
aureus (MRSA) are reportable, regardless 
of community or hospital acquired status.    
 
MRSA is caused by a strain of bacteria 
which is resistant to the antibiotic 
methicillin and many of the antibiotics 
commonly used to treat staphylococcal 
infections. MRSA is becoming more 
common in the community, usually 
presenting as a skin or soft tissue 
infection, considered a non-invasive 
infection.  Non-invasive MRSA infections 
are frequently transmitted to household 
members and close contacts by exposure 
to drainage or infectious secretions. 
Invasive MRSA is when the bacteria  
infects internal systems and is isolated 
from a normally sterile site (such as blood 
or CSF) 
 
Persons with weakened immune systems, 
the elderly, and those with invasive 
medical devices are at increased risk of 
invasive MRSA infections. 
 
• Case total of 90 represents a decrease 
from 120 cases in 2009 
• Median age was 63 years 
• Age range was 2 to 97 years 
• Cases were 43% female and 57% male 
 
To reduce MRSA transmission cover 
wounds with clean dry bandages; wash 
hands frequently with soap and warm 
water; use disinfectants effective against 
S. aureus; avoid sharing personal items 
such as towels, washcloths, razors and 
clothing; tell your healthcare provider if 
you had contact with someone with 
MRSA; and avoid contact sports and 
other skin-to-skin contact until your 
infection heals. Seek medical care 
immediately to identify infection early 
and receive treatment for invasive MRSA 
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Mosquito Borne Infections 
Mosquitoes are found around the world.  Female 
mosquitoes suck blood, making them an 
important disease vector.  There are 45 species of 
mosquitoes in Maine, some of which are capable 
of carrying diseases including EEE and WNV. 
 
Eastern Equine Encephalitis (EEE) 
EEE is a mosquito-borne viral disease that occurs 
in the eastern half of the United States where it 
can cause disease in humans, horses, and some 
birds.  Many persons infected with EEE will have 
no obvious symptoms.  In those persons who do 
develop illness, symptoms of EEE range from 
mild-flu like illness to inflammation of the brain, 
coma, and death.  EEE is regarded as one of the 
most serious mosquito-borne diseases in the 
United States because of its high mortality rate. 
 
In 2010, one turkey tested positive for EEE in 
Maine.  There were no human cases of EEE.  
 
West Nile Virus (WNV) 
WNV occurs throughout the United States and 
can cause disease in humans, birds, and other 
mammals.  Many persons infected with WNV 
will have no obvious symptoms.  In those 
persons who do develop illness, symptoms of 
WNV include:  headache, high fever, altered 
mental state, tremors, convulsions, and rarely 
paralysis.  WNV can also cause meningitis and/
or encephalitis and can be fatal. 
 
In 2010, one mosquito pool tested positive for 
WNV in Maine. 
 
Malaria 
Malaria is a serious and sometime fatal disease 
caused by a parasite that commonly infects a 
certain type of mosquito.  Symptoms may 
include high fevers, shaking chills, flu-like 
illness, headache, muscle aches, tiredness, 
nausea, vomiting and diarrhea.  Malaria is 
uncommon in the United States. 
In 2010, there were six cases of malaria reported in 
individuals who had a history of travel outside the 
US (Haiti, Honduras, Uganda, Cameroon, Ghana, 
Togo, Benin).   
 
Dengue Fever 
Dengue is a disease caused by a virus transmitted 
by the bite of an infected mosquito.  Symptoms of 
dengue fever include high fever, severe headache, 
backache, joint pain, nausea and vomiting, eye pain 
and rash. 
 
In 2010, there were six probable cases of Dengue 
fever reported to the state.  Dengue virus is not 
common in the United States, but has been locally 
acquired in Florida and Hawaii. All cases in 2010 
had travelled internationally (Haiti, US Virgin 
Islands, India, Indonesia) during their exposure 
period.   
 
Prevention  
To lower the chances of contracting a mosquito-
borne disease, measures should be taken to prevent 
mosquito bites: 
• Use an EPA approved insect repellent. 
Products containing DEET, IR3535, picaridin 
or oil of lemon eucalyptus can be applied to 
exposed skin, and permethrin containing 
products can be applied to clothing.  Make sure 
to follow the directions when using repellents 
or other pesticides 
• Wear long sleeve shirts and long pants when 
possible or when mosquitoes are abundant 
• Protect babies with mosquito netting 
• When mosquitoes are especially abundant, stay 
indoors 
• Mosquito proof your house by fixing or 
installing window screens or screen doors 
• Control mosquito populations around your 
home by cleaning gutters, removing or 
emptying objects that contain still water such 
as old tires, old cans,  and plastic tarps  
• Empty water from flower pots, pet dishes, 
birdbaths, rain barrels, and buckets at least 
once a week 
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Pertussis 
2010 Case Total 53 
Maine Rate 4.0 per 100,000 
U.S. rate (2009) 5.5 per 100,000 
Pertussis Incidence, Maine and US, 2006-2010
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Pertussis (whooping cough) is a 
bacterial infection of the respiratory 
tract caused by Bordetella pertussis.  
Prior to vaccine licensure pertussis was 
a common childhood disease associated 
with a high mortality rate. High 
pertussis vaccination rates are 
associated with lower numbers of 
pertussis cases. 
 
Symptoms include an irritating cough 
lasting at least 2 weeks with paroxysm, 
whoop, and vomiting. 
 
• Case total of 53 represents a  decrease 
from 80 cases in 2009 
• The 2005-2009 median number of 
cases per year was 80 
• Median age was 11 years 
• Age range was 6 months to 71 years 
• Cases were 40% female and 60% 
male 
• Penobscot, Knox, Hancock and 
Cumberland counties had the highest 
incidence 
 
Vaccination is available and part of 
routine childhood immunizations.  
There are two pertussis vaccines (DTaP 
and Tdap). Full immunization is 5 DTaP 
shots by the age of 7. The Advisory 
Committee on Immunization Practices 
(ACIP) recommends that persons aged 
10-64 years receive Tdap in place one 
tetanus booster, especially if there is 
close contact with infants. 
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Rabies, Animal 
2010 Case Total 62 
Maine Rate N/A 
U.S. Count (2009) 6,694 
Animal Rabies, Maine, 2001-2010
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Rabies is a viral disease that affects the 
nervous system (brain and spinal cord) of 
humans. Rabies in humans is rare in the 
United States. The vast majority of rabies 
infections are found in wild animals, 
including raccoons, skunks, bats, and 
foxes. Humans usually get rabies from the 
bite of a rabid animal.  It is also possible, 
but quite rare, for people to get rabies if 
infectious material from a rabid animal, 
such as saliva, gets directly into their 
eyes, nose, mouth or a wound.  Because 
rabies has also occurred in people who 
have very close contact with bats without 
an apparent bite, this type of contact is 
also considered a risk and should be 
evaluated by a healthcare provider. 
 
The virus infects the central nervous 
system. The earliest symptoms include 
fever and general discomfort. As the 
disease progresses symptoms may include 
difficulty sleeping, anxiety, confusion, 
hallucinations, excessive drooling, 
difficulty swallowing, and fear of water. 
Death generally follows a few days after 
the onset of symptoms. 
 
• Case total of 62 represents an 
increase from 56 cases in 2009 
• The 2005-2009 median number of 
cases per year was 64 cases 
• The last reported case of human 
rabies in Maine was in 1937 
 
Since rabies infects the central nervous 
system and is not found in the blood of 
infected animals, testing for rabies 
requires central nervous system or brain 
tissue, which must be obtained from the 
animal after it is deceased. Using direct 
fluorescent antibody testing, the state’s 
public health laboratory can determine 
whether or not wild or domestic animals 
that exposed a human or other domestic 
animal have been infected with the virus. 
 
If it is determined that a human has been exposed to an 
infected animal, a course of post-exposure prophylaxis 
(PEP) is recommended. PEP consists of a course of 
immune globulin and vaccine over a 14 day period. In 
2009, guidelines were revised to reduce PEP to a four 
dose course over 14 days. 
 
Human deaths due to rabies in the United States are 
rare. The use of rabies PEP and increased public 
awareness of rabies may reduce the number of 
exposures. Though rabies is generally found in wild 
animals, it is important to keep domestic animals up to 
date on rabies vaccination.  
 
Positive Rabies Results by Species, Maine, 2010 
Animal Number 
Positive 
Raccoon 28 
Skunk 20 
Fox 7 
Bat 5 
Woodchuck 1 
Cat (feral) 1 
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Salmonellosis 
2010 Case Total 133 
Maine Rate 10.1 per 100,000 
U.S. rate (2009) 16.0 per 100,000 
Salmonellosis Incidence, Maine and US, 
2006-2010
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Salmonellosis is a gastrointestinal 
illness of varying severity caused by 
Salmonella bacteria.  Severity of 
symptoms depends on the age and 
overall health of the person infected, 
serotype of salmonella and the site of 
infection. Salmonella is transmitted 
through the ingestion of contaminated 
meat, poultry, eggs, unpasteurized 
dairy, and fresh produce. Handling of 
reptiles, chicks, domestic birds, and pets 
can also lead to transmission. 
 
The symptoms can include fever, 
cramping, diarrhea, nausea, and 
vomiting.  
 
• Case total of 133 represents an 
increase from 121 cases in 2009 
• The 2005-2009 median number of 
cases per year was 159 cases 
• Median age was 41 years 
• Age range was 3 months to 89 years 
• Cases were 56% female and 44% 
male 
• 120 of 133 (90%) cases were 
laboratory confirmed; 13 cases were 
ep idemio logi ca l l y  l inked  t o 
confirmed case 
• 2 cases of typhoid fever were 
diagnosed in individuals who traveled 
to endemic countries 
• The most commonly seen types of 
salmonella were enteritidis, Newport, 
typhimurium, and I 4,[5],12:i:-. 
 
The best way to reduce the risk of 
salmonellosis is by washing produce, 
avoid consuming unpasteurized 
products, and following proper cooking 
instructions. Individuals having contact 
with reptiles (such as snakes, lizards, 
turtles, frogs, iguanas, etc.), birds, and 
farm animals should wash their hands 
immediately after handling these 
animals. 
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Shiga toxin E. coli (STEC) 
2010 Case Total 21 
Maine Rate 1.6 per 100,000 
U.S. rate (2009) 1.5 per 100,000 
STEC Incidence, Maine and US, 2006-2010
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Escherichia coli are common bacteria 
that live in the digestive tract, some 
cause serious infection and some do not. 
Shiga toxin producing E. coli (STEC) 
cause illness, sometimes severe. 
Transmission of STEC is through 
consumption of food or water 
contaminated with fecal matter or 
through contact with farm animals. 
Commonly implicated food items 
include undercooked meats, raw 
vegetables, and unpasteurized products.  
 
Symptoms include abdominal cramping, 
bloody diarrhea and a rare complication, 
hemolytic uremic syndrome (HUS) 
which can damage red blood cells and 
the kidneys. 
 
• Case total of 21 represents an 
increase from 19 cases in 2009 
• The 2005-2009 median number of 
cases per year was 30 
• Median age was 31 years 
• Age range was 1 to 80 years 
• Cases were 57% female and 43% 
male 
• 20 of 21 (95%) cases were laboratory 
confirmed 
• 47% of laboratory confirmed cases 
were O157:H7  
• One hemolytic uremic syndrome 
(HUS) case was reported 
• Cluster of two O26 cases led to 
ground beef recall 
 
STEC prevention measures include: 
handwashing, particularly before and 
after cooking and after contact with 
animals, thoroughly cooking meats, 
washing fresh fruits and vegetables, 
avoiding raw dairy products and 
unpasteur ized  juices ,  avoiding 
consumption of untreated water, and 
avoiding cross-contamination of food 
items. 
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Shigellosis 
2010 Case Total 8 
Maine Rate 0.6 per 100,000 
U.S. rate (2009) 5.2  per 100,000 
Shigellosis Incidence, Maine and US, 2006-2010
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Shigellosis is a gastrointestinal illness 
caused by Shigella bacteria. Shigella is 
highly infectious and can easily be passed 
from one person to another through the 
fecal-oral route. Shigellosis can be 
transmitted by eating contaminated food, 
and drinking, swimming in or playing 
with contaminated water. Outbreaks of 
shigella have also occurred among men 
who have sex with men. 
 
Symptoms include cramping, fever and 
severe diarrhea which may be bloody. 
Children, especially toddlers aged 2 to 4 
years are most likely to get shigellosis. 
 
• Case total of 8 represents an increase 
from 5 cases in 2009 
• The 2005-2009 median number of 
cases per year was 14 
• Median age was 42 years 
• Age range was 22 to 62 years 
• Cases were 38% female and 62% male 
• All 8 cases were laboratory confirmed 
• Shigella sonnei and flexneri were 
isolated from  samples 
• 50% of cases had travel to a foreign 
country 
 
To prevent shigellosis, practice good hand 
hygiene, use pasteurized milk products,  
use filtered, clean water, and store foods 
properly.  Infected persons who are in 
childcare, healthcare, or food handling are 
restricted from work until infection clears 
and there is no evidence of Shigella in 
stool specimens. Shigellosis is more 
common in the developing world and 
travelers should take extra precautions. 
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Streptococcus pneumoniae,  
invasive  
2010 Case Total 130 
Maine Rate 9.9 per 100,000 
U.S. rate (2009) Not available 
Drug Resistant S. pneumoniae  Incidence, Maine 
and US, 2006-2010
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Starting in 2010, all cases of invasive 
disease were investigated. 
 
Invasive pneumococcal disease occurs 
when the Streptococcus pneumoniae 
bacterium infects the blood, lungs, or 
brain.  Disease is transmitted from person 
to person through droplets when an 
infected person coughs or sneezes.  Types 
of illness include bacteremia, meningitis, 
and pneumonia.  There are over 90 
different serotypes of S. pneumoniae, but 
the majority of pneumococcal disease is 
caused by a few common serotypes.   
 
Persons at risk of pneumococcal disease 
include young children, adults 65 years of 
age or older, persons with certain 
underlying medical conditions, persons 
with weakened immune systems, and 
those in congregate settings such as 
daycare and long-term care facilities. 
 
• 130 invasive S. pneumoniae cases 
reported, of which 30 were drug 
resistant 
• Median age for  invasive cases was 61 
years 
• Age range for invasive cases was 1 to 
99 years 
• Cases were 42% female and 58% male 
• 10 cases were in children under the age 
of five, of which 3 were drug resistant 
 
Pneumococcal disease can be prevented 
through routine vaccination of infants and 
children under five with the 
pneumococcal conjugate vaccine 
(PCV13) and vaccination of adults and 
children over the age of two who are at 
high risk of infection with the 
pneumococcal polysaccharide vaccine 
(PPV23).  
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 Early Syphilis 
2010 Case Total 39 
Maine Rate 2.9 per 100,000 
U.S. rate (2009) 4.6 per 100,000 
Early Syphilis Incidence, Maine and US,                         
2006-2010
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Syphilis is a sexually transmitted 
disease (STD) caused by the bacterium 
Treponema pallidum.  It has often been 
called “the great imitator” because so 
many of the signs and symptoms of 
syphilis are like those of other diseases.  
 
Early syphilis is defined as disease that 
occurs within the first year of infection.  
This is inclusive of the primary, 
secondary and early latent stages of the 
disease.   
 
Syphilis is primarily spread through 
direct contact with a primary syphilis 
sore.  Sores typically occur on the 
external genitals, vagina,  and around 
the anus, but are also seen on the lips 
and in the mouth.  Transmission 
primarily occurs during vaginal, anal, or 
oral sex when contact is made with a 
primary sore.  Disease transmission can 
also occur during the infectious period 
of the secondary stage, via the 
condylomata lata (raised moist papules) 
on the genital area or mucous patches in 
the mouth.  Pregnant women with 
syphilis can pass it to their baby.  
Genital sores caused by syphilis make it 
easier to transmit and acquire HIV 
infection.   
 
• Case total of 39 represents a 179% 
increase from 2009 
• The 2005-2009 median number of 
cases per year was 14 
• Cases were 100% male, no female 
cases were reported 
 
Many individuals infected with syphilis reach a latent stage 
and have no symptoms for years, but they are still at risk for 
later complications (damage to internal organs, nerve 
damage, blindness and dementia) and death if not treated.  
 
Syphilis transmission can be prevented by the use of latex or 
polyurethane condoms and dental dams during anal, vaginal, 
and oral sex. Prevention and control efforts include targeted 
awareness messaging  (including the internet) and disease 
intervention activities for all early syphilis cases, including 
ensuring adequate treatment, partner notification, and efforts 
to identify public sex environments that outreach educators 
can target in their work.   
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Tuberculosis 
2010 Case Total 8 
Maine Rate 0.6 per 100,000 
U.S. rate (2009) 3.7 per 100,000 
Tuberculosis Incidence, Maine and US, 
2006-2010
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Tuberculosis (TB) is a communicable 
disease caused by the bacterium, 
Mycobacterium tuberculosis.  It is 
spread through the air by airborne 
particles called droplet nuclei that are 
expelled from the lungs when a person 
who has infectious TB coughs, sings or 
sneezes.  TB infection begins when the 
mycobacterium is inhaled into the lung 
and begins to multiply.  Usually, the 
body is able to contain the infection so 
that disease does not develop. This is 
known as latent TB infection (LTBI) 
and is not infectious to others.  
 
TB can cause infection  in the lung 
(pulmonary), which is considered 
infectious to others. TB also causes 
infection outs ide of the  lung 
(extrapulmonary), which is not 
infectious. 
 
• Case total of 8 represents a decrease 
from 9 cases in 2009 
• Lowest case rate in the country in 
2010 
• The 2005-2009 median number of 
cases per year was 16  
• Median age was 30 years 
• Age range was 2 to 80 years 
• Cases were 75% female and 25% 
male 
• 7 of 8 cases (88%) were foreign born 
• In 2 contact investigations, 96% of 
identified contacts were evaluated 
• Of 420 LTBI reports, 80% were 
foreign born 
 
All cases are evaluated by a TB 
consultant physician and are placed on 
directly observed therapy (DOT) 
administered by Public Health Nurses.  
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Varicella 
2010 Case Total 247 
Maine Rate 18.8  per 100,000 
U.S. rate (2009) 6.7 per 100,000 
Varicella Incidence, Maine and US, 2006-2010
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Varicella (chickenpox) is a highly 
contagious viral disease of which 
humans are the only source of infection.   
In most cases the primary symptom is 
an itchy skin rash that looks like 
blisters, covering the body but  more 
evident on the face, scalp, and abdomen. 
The majority of infected individuals 
develop a fever just before or when the 
rash appears.  
 
Person-to-person transmission occurs 
primarily through direct contact with 
respiratory tract secretions of infected 
individuals and is  transmitted 
occasionally via the airborne route.  
Adolescents and adults are more at risk 
for severe disease which could include 
pneumonia, bacterial infection of the 
skin and swelling of the brain.  
 
• Case total of 247 represents an 
increase from 235 cases in 2009 
• Overall the greatest incidence was 
during the fall and spring months 
while school was in session 
• Nationally varicella incidence is 
reported to be an underestimate of 
true incidence 
 
Varicella vaccine is a live attenuated 
viral vaccine.  A two-dose series is 
estimated to be more than 90% effective 
in preventing infection. Federal CDC 
and ACIP recommend all children 
receive 2 doses of vaccine. 
Breakthrough infection has been 
reported in vaccinated individuals.  
 
Mandatory vaccination for varicella 
(one dose) was phased in as of 2003 and 
is now a requirement for school 
admission.   
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Vibriosis 
2010 Case Total 5 
Maine Rate 0.4 per 100,000 
U.S. rate (2009) 0.3 per 100,000 
Vibriosis Incidence, Maine and US, 2006-2010
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Vibriosis is an infection of variable 
severity characterized by diarrhea and 
vomiting, primary septicemia, or wound 
infections. Vibrio parahaemolyticus, 
associated with ingestion of raw or 
undercooked seafood, and Vibrio 
alginolyticus, associated with wounds and 
water contact, are the primary causes of 
vibriosis in Maine. 
 
• Case total of 5 represents an increase 
from 4 cases in 2009 
• The 2005-2009 median number of 
cases was 3  
• Median age was 58 years 
• Age range was 18 to 80 years 
• Cases were 20% female and 80% male 
• Vibrio alginolyticus, parahaemolyticus,  
and vulnificus were isolated. 
 
Vibrio infections caused by V. 
parahaemolyticus can be prevented by 
thoroughly cooking seafood, especially 
oysters.  Wound infections can be 
prevented by avoiding exposure of open 
wounds to seawater.   Maine CDC works 
closely with the Maine Department of 
Marine Resources when cases of vibriosis 
report exposures to shellfish or other 
marine sources of illness.  
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Influenza Season 2010—2011 
Influenza 
Influenza is a viral illness that typically occurs 
during the winter months. It is characterized by 
the abrupt onset of constitutional and 
respiratory signs and symptoms such as fever, 
headache, non-productive cough, sore throat, 
and runny nose.  Influenza is spread from 
person to person primarily through coughing 
and sneezing of infected persons.  Influenza 
can be diagnosed through laboratory testing.  
Influenza-like illness (ILI) is defined as fever 
greater than or equal to 100°F (37.8°C) AND 
cough and/or sore throat in the absence of a 
known cause.  
 
The purpose of influenza surveillance is to 
inform influenza prevention and control policy.  
Maine CDC conducted influenza surveillance 
in collaboration with thirty-three health care 
providers, four hospitals, three laboratories, 
one city vital records office, and twenty four 
hospital emergency departments during the 
reporting period from October 3, 2010 to May 
21, 2011.  This report summarizes 2010-11 
influenza surveillance by key indicators.   
 
 
Influenza Surveillance in Maine 
 
Outbreaks 
Outbreaks of influenza or influenza-like illness are 
reportable by law in Maine.  The definition used to 
recognize outbreaks of influenza-like illness varies 
by setting.  During the 2010-11 season, a total of 
61 outbreaks of influenza were reported in Maine. 
This is a decrease from the 2009-10 season when 
204 outbreaks were reported, mostly due to 
pandemic H1N1. Of the 61 outbreaks, 44 were in 
long-term care facilities, 1 was in an acute care 
facility, 12 in K-12 schools, 1 in a university 
settings, and 3 in other institutions.  Outbreaks 
occurred in all of the eight districts in the state.   
 
Death Certificates 
The vital records office of Bangor reported the 
number of death certificates in which pneumonia 
and/or influenza were mentioned as the primary or 
secondary cause of death.  Data reported represent 
deaths that occurred in the reporting area, not the 
residence of the deceased.  During the 2010-11 
season, a total of 737 deaths were reported by this 
vital records office.  Of these 88 (11.9%) were 
attributed to pneumonia or influenza.   
 
Pediatric Fatalities 
Health care providers and the Office of the Medical 
Examiner report deaths in persons aged 18 years or 
younger associated with laboratory-confirmed 
influenza to Maine CDC.  One influenza-associated 
pediatric death was reported in a vaccinated child 
from York county during the 2010-11 influenza 
season. 
Appendix A 
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Influenza Season 2010—2011 
Outpatient influenza-like illness (ILI) 
Data on outpatient visits for ILI  was 
collected through the U.S. Outpatient 
Influenza-like Illness Surveillance 
Network (ILINet), a collaborative effort 
between federal CDC, Maine CDC, and 
local health care providers.  During the 
2010-11 season, 33 health care 
providers reported the total number of 
patients seen in their practices and the 
number of those patients seen for ILI by 
age group on a weekly basis.  
Outpatient ILI visits in Maine peaked 
during the middle of February (MMWR 
week 7).  The New England region 
peaked a week later than the Maine 
region.   
 
Hospital Inpatients 
Inpatient surveillance for respiratory 
illness admissions in Maine was 
conducted in collaboration with four 
hospitals.  During the 2010-11 season, 
four hospitals reported the number of 
patients admitted to the hospital and the 
number of those patients admitted for 
influenza  or pneumonia using admitting 
diagnoses.  Hospital admissions for 
influenza, pneumonia, or respiratory 
illness were highest in the first week of 
March (MMWR week 9). 
 
Emergency Room Visits 
Syndromic surveillance was conducted 
in the Emergency Departments of 24 
hospitals and analyzed using the Early 
Aberration Reporting System (EARS).  
These visits are grouped by chief 
complaint.  The percentage of ED visits 
that had a chief complaint consistent 
with ILI peaked in February (MMWR 
week 8) 
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HETL 
M a i n e  C D C ’ s  H e a l t h  a n d 
Environmental Testing Laboratory 
(HETL) worked collaboratively with 
hospitals and private laboratories to 
collect specimens for respiratory virus 
testing and influenza positive isolate 
subtyping.  HETL reported the number 
of specimens received for respiratory 
virus testing and the number positive for 
influenza A(H1), A(H3), A(pH1N1), A 
(unable to subtype), and influenza B by 
specimen collection date.  During the 
2010-11 season, 959 respiratory 
specimens were tested by HETL for 
influenza.  Of those 411 (42.9%) were 
positive for influenza (1 for influenza 
A/H1, 114 for influenza A/H3, 166 for 
influenza A/pH1N1, 4 for influenza A 
unable to subtype, and 126 for influenza 
B). 
 
Reference Labs 
Two Maine reference laboratories, and 
many national reference laboratories 
submitted reports of laboratory-
confirmed influenza by culture or 
reverse-transcriptase polymerase chain 
reaction (RT-PCR).  During the 2010-
11 season,  602 specimens were positive 
for influenza (94 for influenza A/H3, 
107 for influenza A/pH1N1, 237 for 
influenza A without subtype, and 164 
for influenza B). 
 
Rapid testing 
Many hospitals, labs, and physician 
offices voluntarily report positive rapid 
antigen tests to the state.  During the 
2010-11 season 280 positive tests were 
reported, 219 for influenza A, 54 for 
influenza B, and 7 for influenza, 
unsubtyped.   
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Brucellosis Case Series—Maine, 2010 
Brucellosis is a bacterial disease that can affect many species of animals, including cattle, buffalo, bison, 
pigs, sheep, goats, elk, dogs and horses. Four species of brucella may infect humans including: B. 
abortus (from cattle, bison), B. suis (from swine, cattle, bison), B. melitensis (from goats) and rarely, B. 
canis (from dogs).  Brucellosis is also known as Undulant Fever, Malta Fever, and Mediterranean Fever. 
 
Brucellosis is spread to humans by direct contact with living or dead infected animals’ secretions, 
tissues, blood, urine, vaginal discharges, aborted fetuses, and especially, placentas. Animals become 
infected through ingestion of contaminated discharges, food or water. Humans become infected by direct 
contact with infected materials; with mucosal surfaces or non-intact skin; ingestion of raw milk and 
dairy products; and inhalation of contaminated aerosols, especially in the laboratory setting. There is no 
evidence of person-to-person transmission. Symptoms include fever, sweats, fatigue, malaise, anorexia 
and arthralgia. Symptoms occur 2-10 weeks after exposure. 
 
In 2010, two unrelated human cases of brucellosis were reported to Maine CDC. Both cases presented 
with mild illness and significant food and travel history.  Prior to these two cases, the last known case in 
Maine occurred in 2003. An average of 150 cases are reported in the United States each year.  
 
 Case 1. A 54 year old female reported fever, headache, chills, fatigue, muscle aches, and night 
 sweats after recent international travel. The case reported consumption of goat meat and raw 
 camel’s milk.  Blood cultures were drawn when the patient was evaluated. A suspect Brucella 
 specimen was forwarded to the Health and Environmental Testing Laboratory (HETL) for 
 confirmation. B. melitensis was identified as the causative agent. 
 
 Case 2. A 66 year old male presented to his primary care provider with an acute onset of fever, 
 chills, and arthralgia. The case reported a recent history of wild boar hunting and was injured 
 while field dressing the swine.  While symptomatic, the case had invasive surgical procedures.  
 A blood specimen was sent to HETL for confirmatory testing when Brucella was suspected.  
 B. suis was identified as the causative agent. 
 
Brucellosis is a rare condition in Maine.  These cases highlight the importance of eliciting travel and 
exposure history that may inform differential diagnosis.  Both cases were initially reported through 
laboratory surveillance.  Initial laboratory testing lead to suspicion of Brucella, which subsequently 
triggered notification to HETL as indicated through the laboratory response network.   
 
Healthcare workers can be exposed to Brucella during aerosol-generating procedures or handling 
laboratory cultures without biosafety level-3 precautions.  A number of health care workers were 
exposed to Brucella during the care and diagnosis of these patients and were recommended to receive 
prophylactic treatment and post exposure testing. None of the persons exposed developed brucellosis.   
Appendix B 
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Pertussis Outbreak Associated with a Daycare—Maine, 2010 
Background: Pertussis (whooping cough) is an acute respiratory disease caused by the Bordetella 
pertussis bacterium.   Transmission from person to person occurs via inhalation of droplets produced 
from coughing and sneezing.  The time between exposure to symptoms can be up to 21 days (usually 7-
10 days).  Early symptoms (catarrhal stage) include mild cough, sneezing, runny nose, and low-grade 
fever.  Symptoms then progress (paroxysmal stage) to paroxysmal cough, post-tussive vomiting, and 
apnea.  Young children and infants often in-draw air after a coughing spell, making a sound referred to 
as a “whoop.”  Symptoms can last for several weeks to several months (convalescent stage).  Without 
treatment, a person with pertussis is contagious for 21 days. 
 
Methods: In August 2010, Maine CDC received a report of a laboratory confirmed case of pertussis in a 
child who attended a home daycare.  A case investigation was conducted by Maine CDC to identify 
exposed persons, search for additional cases, and implement control measures to prevent further 
transmission in a highly susceptible population.  An interview with the daycare owner revealed that 
several other children in the daycare were symptomatic and that several children did not have a history 
of immunization with a pertussis vaccine.  An outbreak investigation yielded the following findings. 
 
Results: A total of 14 children were enrolled in the daycare, 4 (29%) of which were confirmed cases of 
pertussis with onset dates ranging from 6/30/10 – 7/28/10; two of these cases were laboratory confirmed.  
A fifth case was confirmed in a school-aged sibling of a daycare attendee.  The median age of cases was 
4 years (range 3-9); 60% of cases were male. The mean incubation period was 16 days (range 13-22).  
Three cases had never received a dose of pertussis vaccine and one had only received two doses of 
vaccine.  No hospitalizations or deaths were associated with the outbreak 
 
Control measures included the following: 
• Testing was recommended for all symptomatic children in the daycare and any symptomatic 
contacts 
• 35 case contacts were recommended to receive antibiotic prophylaxis 
• An informational letter was distributed to parents with recommendations  
• Symptomatic persons were excluded from work/school/social activity for the first 5 days of 
treatment 
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Healthcare Associated Infections 
Healthcare Associated Infections (HAIs) are among the top ten causes of death in the U.S. It is estimated 
that 1.7 million HAIs occur per year in U.S., and results in 99,000 deaths, at a cost of $33 billion.  
Because HAIs have a significant impact on health and heathcare costs, there is a growing focus on the 
need to monitor and prevent HAIs.  In 2009, the Maine CDC received federal funds to develop an HAI 
prevention program.  The Maine CDC works closely with an advisory group which has representatives 
from all Maine hospitals. Additionally, Maine CDC coordinates with other state and federal agencies, 
healthcare providers, and professional groups to prevent HAIs.  The focus of the program is for hospitals 
to report HAIs using uniform nationally recognized definitions which the program will validate.  In 
particular, the focus is to reduce: 
1. Central Line Associated Bloodstream Infections 
2. Methicillin Resistant Staphylococcus aureus (MRSA) infections 
3. Surgical Site Infections. 
 
Accomplishments to date: 
• Creation of a new infrastructure within Maine CDC for the HAI program. 
• HAI program is working closely with the Maine Health Data Organization and the Maine 
Quality Forum to streamline HAI reporting by hospitals. 
• The HAI program has provided data management support and epidemiology training for 
Infection Preventionists. Maine CDC supported a statewide training on developing an antibiotic 
surveillance program attended by physicians and pharmacists. 
• Maine CDC has provided training on hospital outbreak investigations, and improved healthcare 
facility outbreak reporting to Maine CDC. 
• Maine CDC has created an HAI website for the general public. 
• Increased state lab capacity to identify organisms likely to cause HAI outbreaks. 
 
HAI program future projects include: 
• Enhance data surveillance for MRSA-HAI, Clostridium difficile-HAI, carbapenem resistant 
gram negative rods, and central line infections. 
• Validate reported HAI data. 
• Continue to supply assistance for outbreaks occurring in hospitals and Long Term Care 
Facilities. 
• Prove additional training on infection prevention to Long Term Care Facilities. 
• Increase surveillance in dialysis units. 
 
FAQ: Has Maine reduced HAIs? 
Yes.  Through the efforts of multiple state agencies and professional organizations, Maine has reduced 
central line associated bloodstream infections by over 50%, from 2008 to 2010.  Through an active 
surveillance study, hospitals have been able to identify carriers of MRSA, and protect other patients 
from becoming infected.  Now that hospitals are reporting standardized data on National Healthcare 
Safety Network (NHSN) about HAI-MRSA, Maine CDC will be able to analyze reductions in MRSA-
HAIs over time. 
Appendix D 
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2010 Tick Data Collected by the Maine Medical Center Research Institute 
Vector-Borne Disease Laboratory 
 
The Maine Medical Center Research Institute (MMCRI) Vector-Borne Disease 
Laboratory operates a free tick identification service as part of a program to establish the 
distribution of deer ticks (Ixodes scapularis) in the state. Ticks found on people and pets 
are submitted with information on where the tick(s) may have been acquired. Ticks are 
not tested for the presence of Lyme bacteria and MMCRI only accepts ticks from the 
state of Maine. 
 
It is important to note that this passive sampling could be influenced by a variety of 
extraneous factors (e.g. proximity to the laboratory, level of citizen concern about Lyme 
disease in an area, or whether or not a particular area is already widely known to have a 
deer tick presence). 
 
Tick Identification by County, Maine, 2010 
 County 
Ixodes 
scapularis 
(Deer 
Tick) 
Dermacentor 
variabilis 
(American 
Dog Tick) 
Ixodes 
cookei 
(Woodchuck 
Tick) 
Other 
ticks 
Androscoggin 36 5 0 0 
Aroostook 4 0 0 1 
Cumberland 188 45 1 2 
Franklin 11 7 0 0 
Hancock 162 15 4 0 
Kennebec 94 16 0 0 
Knox 59 20 1 1 
Lincoln 23 6 0 0 
Oxford 22 18 1 0 
Penobscot 142 11 3 0 
Piscataquis 20 7 3 4 
Sagadahoc 47 5 0 0 
Somerset 26 18 1 0 
Waldo 71 4 3 2 
Washington 33 4 0 1 
York 71 15 1 0 
Unspecified 22 3 0 1 
Totals 1,031 199 18 12 
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Why is it important to submit ticks for identification? 
It is important for a physician (or a pet's veterinarian) to know what species of tick was 
involved in a bite.  It is also important for surveillance purposes to know the type of tick 
and where ticks are found. 
 
How are ticks submitted? 
Remove ticks by grasping them with fine tweezers as near to the skin as possible and 
pull up gently but firmly.  The barbed mouth parts may not let go easily.  It may take 
several minutes or more.  Do not handle ticks with bare hands.  
Ticks should be sealed in a small, crushproof vial of 70% alcohol.  The vial should be 
padded with absorbent paper towel and sealed in a plastic bag, and mailed along with a 
completed submission form to:  
Vector-borne Disease Laboratory 
Maine Medical Center Research Institute 
75 John Roberts Rd., Suite 9B  
South Portland, ME 04106  
Print out the submission form from http://www.mmcri.org/lyme/lymeform.html, complete 
it, and mail it in with the specimen.  A report of the tick's identification will be sent to the 
submitter as soon as possible, usually within five days. A map may also be sent to assist 
in the identification of the site where tick exposure occurred. The public may address 
questions to the laboratory’s email address: ticklab@mmc.org. 
 
 
Map Caption 
A map summarizing the number of Ixodes scapularis (deer tick) submitted per Minor 
Civil Division, 1989 through 2010. 
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  NOTIFIABLE CONDITIONS LIST   
  Maine Department of Health and Human Services  
    Center for Disease Control and Prevention 
  
           Conditions in BOLD must be reported immediately   All others must be reported in 48 hours 
 
 
Reportable Disease or Condition Laboratory Specimen Submission 
Acquired Immunodeficiency Syndrome (AIDS) 
Anthrax   
Arboviral Infection  
Babesiosis 
Botulism  
Brucellosis  
Campylobacteriosis 
Carbon Monoxide Poisoning, including 
- Clinical signs, symptoms or known 
exposure consistent with diagnosis of  
        carbon monoxide poisoning and/or: 
        a carboxyhemoglobin (COHb) level  
        >5% 
Chancroid 
Chlamydia 
Chickenpox (Varicella) 
Creutzfeldt-Jakob disease, <55 years of age 
Cryptosporidiosis 
Dengue 
Diphtheria  
E. coli, Shiga toxin-producing (STEC) disease  
   including E. coli: 0157:H7                                                                                                                                                                        
Ehrlichiosis 
Giardiasis 
Gonorrhea 
Haemophilus influenzae disease, invasive,    
   include all serotypes           
Hantavirus, pulmonary syndrome 
Hemolytic-uremic syndrome (post-diarrheal) 
Hepatitis A, B, C, D, E (acute) 
Hepatitis B (chronic, and/or perinatal) 
Hepatitis C (chronic) 
Hepatitis, acute (etiologic tests pending or  
  etiology unknown) 
Human Immunodeficiency Virus (HIV), 
   including: 
- Confirmed, positive antibody tests 
- Viral load tests, all results  
- CD4 lymphocyte counts, all results  
Influenza-associated pediatric death  
Influenza-like illness outbreaks 
Influenza A, Novel 
Legionellosis 
Leptospirosis 
Listeriosis  
Lyme Disease  
Malaria 
Measles   
Meningitis (bacterial) 
Meningococcal Invasive Disease  
Mumps  
Paralytic Shellfish Poisoning 
Pertussis  
Plague 
Poliomyelitis 
Psittacosis 
Q Fever  
Rabies (human and animal)  
Rabies Post-Exposure Prophylaxis 
Ricin Poisoning  
Rocky Mountain Spotted Fever 
Rubella (including congenital)  
Salmonellosis  
Severe Acute Respiratory Syndrome  
  (SARS) 
Shigellosis  
Smallpox  
Staphylococcus aureus, Methicillin-
  Resistant (MRSA) invasive,  
Staphylococcus aureus with     
  resistance (VRSA) or intermediate   
  resistance (VISA) to Vancomycin     
  isolated from any site 
Staphylococcal enterotoxin B  
Streptococcal invasive disease, Group A 
Streptococcal invasive disease, Group B 
Streptococcus pneumoniae, invasive          
  disease                                                         
Syphilis 
Tetanus  
Toxoplasmosis 
Trichinosis  
Tuberculosis (active and presumptive  
  cases)    
Tularemia  
Unusual or increased case incidence,  
  critical illness, unexplained death(s) 
  of any suspect infectious disease 
Vibrio species, including Cholera  
Viral Hemorrhagic Fever 
Venezuelan equine encephalitis 
Yellow Fever 
Yersiniosis 
Directors of laboratories are to submit cultures or clinical 
specimens for the following to the Maine Health and 
Environmental Testing Laboratory for confirmation, typing 
and/or antibiotic sensitivity:   
 
Acid-Fast Bacillus 
Bacillus anthracis 
Bordetella pertussis 
Brucella species 
Clostridium tetani 
Clostridium botulinum 
Corynebacterium diphtheriae 
Coxiella burnetii 
Escherichia coli, Shiga toxin-producing 
Haemophilus influenzae 
Human Immunodeficiency Virus 
Influenza virus, Novel 
Listeria monocytogenes 
Mumps virus 
Mycobacterium tuberculosis 
Neisseria meningitidis 
Rabies virus 
Ricin Poisoning 
Rubella virus 
Rubeola virus 
Salmonella species 
SARS Coronavirus 
Shigella species 
Toxoplasma gondii 
Variola virus 
Vibrio species 
Yersinia pestis 
 
 
 
 
 
 
 
 
 
Who must report: Health Care Providers, Medical Laboratories, Health Care Facilities, 
Administrators, Health Officers, Veterinarians 
When to report: 
 Conditions in BOLD are reportable immediately by telephone on recognition or strong 
suspicion of disease 
 All others are reportable by telephone, fax, or mail within 48 hours of recognition or 
strong suspicion of disease 
What to report: 
Disease reports must include as much of the following as is known: 
 Disease or condition diagnosed or suspected 
 Patient’s name, date of birth, address, phone number, occupation and race 
 Diagnostic laboratory findings and dates of test relevant to the notifiable condition 
 Health care provider name, address and phone number 
 Name and phone number of person making the report 
 
Complete Rules for the Control of Notifiable Conditions at: 
http://www.maine.gov/dhhs/boh/ddc/epi/disease-reporting/index.shtml  
 
 
 
 April 4, 2008 
Disease Reporting 
24 Hours A Day 
7 Days A Week  
 
Telephone 
1-800-821-5821 
 
Fax 
1-800-293-7534 
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Department of Health and Human Services 
Maine Center for Disease Control and Prevention 
State House Station #11 
Augusta, ME  04333-0011 
 
Paul R. LePage 
Governor 
 
Mary Mayhew 
Commissioner 
 
Sheila Pinette, DO 
Director, Maine Center for Disease Control and Prevention 
 
 
 
 
The Department of Health and Human Services (DHHS) does not discriminate on the 
basis of disability, race, color, creed, gender, age, sexual orientation, or national origin, in 
admission to, access to or operation of its programs, services, activities, or its hiring or 
employment practices.  This notice is provided as required by Title II of the Americans 
with Disabilities Act of 1990 and in accordance with the Civil Rights Acts of 1964 as 
amended.  Section 504 of the Rehabilitation Act of 1973 as amended, the Age 
Discrimination Act of 1975, Title IX of the Education Amendments of 1972 and the 
Maine Human Rights Act.  Questions, concerns, complaints, or requests for additional 
information regarding civil rights may be forwarded to the DHHS’ ADA 
Compliance/EEO Coordinator, State House Station #11, Augusta, Maine 04333, 207-
287-4289 (V) or 207-287-3488 (V), TTY: 800-606-0215.  Individuals who need auxiliary 
aids for effective communication in programs and services of DHHS are invited to make 
their needs and preferences known to the ADA Compliance/EEO Coordinator.  This 
notice is available in alternate formats, upon request. 
 
 
 
 
